US20220354767A1 - Method of Thickening Cosmetic Composition - Google Patents
Method of Thickening Cosmetic Composition Download PDFInfo
- Publication number
- US20220354767A1 US20220354767A1 US17/873,515 US202217873515A US2022354767A1 US 20220354767 A1 US20220354767 A1 US 20220354767A1 US 202217873515 A US202217873515 A US 202217873515A US 2022354767 A1 US2022354767 A1 US 2022354767A1
- Authority
- US
- United States
- Prior art keywords
- acid
- mass
- sodium
- ether
- molecular weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 46
- 239000002537 cosmetic Substances 0.000 title claims abstract description 44
- 230000008719 thickening Effects 0.000 title abstract description 5
- 239000000203 mixture Substances 0.000 title description 54
- -1 poly(2-acrylamido-2-methylpropanesulfonic acid) Polymers 0.000 claims abstract description 90
- 229920000642 polymer Polymers 0.000 claims abstract description 56
- 150000003839 salts Chemical class 0.000 claims abstract description 35
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 32
- 239000004584 polyacrylic acid Substances 0.000 claims abstract description 14
- 150000002433 hydrophilic molecules Chemical class 0.000 claims abstract description 9
- 238000010298 pulverizing process Methods 0.000 claims abstract description 3
- 229920001577 copolymer Polymers 0.000 claims description 41
- 239000002253 acid Substances 0.000 claims description 16
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims description 13
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 12
- 238000004132 cross linking Methods 0.000 claims description 8
- 229940106010 beheneth-25 Drugs 0.000 claims description 6
- 229920006037 cross link polymer Polymers 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 1
- 238000001879 gelation Methods 0.000 abstract description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 44
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 42
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 40
- 238000009472 formulation Methods 0.000 description 35
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 35
- 235000019441 ethanol Nutrition 0.000 description 33
- 230000015572 biosynthetic process Effects 0.000 description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 30
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 30
- 238000003786 synthesis reaction Methods 0.000 description 30
- 239000003921 oil Substances 0.000 description 26
- 235000019198 oils Nutrition 0.000 description 26
- 230000000052 comparative effect Effects 0.000 description 25
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 24
- 235000011187 glycerol Nutrition 0.000 description 24
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 23
- 235000014113 dietary fatty acids Nutrition 0.000 description 22
- 239000000194 fatty acid Substances 0.000 description 22
- 229930195729 fatty acid Natural products 0.000 description 22
- 238000002156 mixing Methods 0.000 description 22
- 229910052708 sodium Inorganic materials 0.000 description 22
- 239000011734 sodium Substances 0.000 description 22
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 21
- 238000006116 polymerization reaction Methods 0.000 description 21
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 20
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 17
- 239000008213 purified water Substances 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- 239000007864 aqueous solution Substances 0.000 description 16
- 150000001875 compounds Chemical class 0.000 description 16
- 239000004205 dimethyl polysiloxane Substances 0.000 description 16
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 16
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 16
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 16
- 238000010560 atom transfer radical polymerization reaction Methods 0.000 description 15
- 239000000839 emulsion Substances 0.000 description 15
- 239000004166 Lanolin Substances 0.000 description 14
- 239000004359 castor oil Substances 0.000 description 14
- 235000019438 castor oil Nutrition 0.000 description 14
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 14
- 235000019388 lanolin Nutrition 0.000 description 14
- 229940039717 lanolin Drugs 0.000 description 14
- 239000000178 monomer Substances 0.000 description 14
- 229960005323 phenoxyethanol Drugs 0.000 description 14
- 238000010526 radical polymerization reaction Methods 0.000 description 14
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 13
- 239000000499 gel Substances 0.000 description 13
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N stearyl monoglyceride Natural products CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 150000001298 alcohols Chemical class 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 229940048053 acrylate Drugs 0.000 description 11
- 229920001296 polysiloxane Polymers 0.000 description 11
- 239000002562 thickening agent Substances 0.000 description 11
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 10
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 10
- 230000003796 beauty Effects 0.000 description 10
- 229940008099 dimethicone Drugs 0.000 description 10
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 10
- 229940058015 1,3-butylene glycol Drugs 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 235000019437 butane-1,3-diol Nutrition 0.000 description 9
- 239000002304 perfume Substances 0.000 description 9
- 238000012712 reversible addition−fragmentation chain-transfer polymerization Methods 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 8
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 8
- 239000012987 RAFT agent Substances 0.000 description 8
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 8
- 229960000735 docosanol Drugs 0.000 description 8
- 150000004665 fatty acids Chemical class 0.000 description 8
- 229920001223 polyethylene glycol Polymers 0.000 description 8
- 229920001285 xanthan gum Polymers 0.000 description 8
- 239000000230 xanthan gum Substances 0.000 description 8
- 235000010493 xanthan gum Nutrition 0.000 description 8
- 229940082509 xanthan gum Drugs 0.000 description 8
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 7
- 238000009826 distribution Methods 0.000 description 7
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 7
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 7
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 7
- 229960000401 tranexamic acid Drugs 0.000 description 7
- 239000001993 wax Substances 0.000 description 7
- AISZNMCRXZWVAT-UHFFFAOYSA-N 2-ethylsulfanylcarbothioylsulfanyl-2-methylpropanenitrile Chemical compound CCSC(=S)SC(C)(C)C#N AISZNMCRXZWVAT-UHFFFAOYSA-N 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
- 239000002202 Polyethylene glycol Substances 0.000 description 6
- 239000008272 agar Substances 0.000 description 6
- 235000010419 agar Nutrition 0.000 description 6
- 230000001404 mediated effect Effects 0.000 description 6
- 150000005846 sugar alcohols Polymers 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 5
- 229920001214 Polysorbate 60 Polymers 0.000 description 5
- 239000012190 activator Substances 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 229960003237 betaine Drugs 0.000 description 5
- 239000012986 chain transfer agent Substances 0.000 description 5
- 239000003240 coconut oil Substances 0.000 description 5
- 239000008341 cosmetic lotion Substances 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 239000001509 sodium citrate Substances 0.000 description 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 5
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 5
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 5
- 159000000000 sodium salts Chemical class 0.000 description 5
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 description 5
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 5
- 229940099259 vaseline Drugs 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 4
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 4
- 235000021357 Behenic acid Nutrition 0.000 description 4
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 4
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 4
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229940116226 behenic acid Drugs 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 235000019864 coconut oil Nutrition 0.000 description 4
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 229940075529 glyceryl stearate Drugs 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- 230000000704 physical effect Effects 0.000 description 4
- 229920000058 polyacrylate Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 150000004804 polysaccharides Chemical class 0.000 description 4
- 230000027756 respiratory electron transport chain Effects 0.000 description 4
- 235000019983 sodium metaphosphate Nutrition 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 239000008117 stearic acid Substances 0.000 description 4
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 3
- WHNPOQXWAMXPTA-UHFFFAOYSA-N 3-methylbut-2-enamide Chemical compound CC(C)=CC(N)=O WHNPOQXWAMXPTA-UHFFFAOYSA-N 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 3
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 3
- 239000004386 Erythritol Substances 0.000 description 3
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 3
- 229920002148 Gellan gum Polymers 0.000 description 3
- 235000019482 Palm oil Nutrition 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 125000005250 alkyl acrylate group Chemical group 0.000 description 3
- 239000002280 amphoteric surfactant Substances 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 229910052786 argon Inorganic materials 0.000 description 3
- 239000012300 argon atmosphere Substances 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 229940092738 beeswax Drugs 0.000 description 3
- 229940110830 beheneth-25 methacrylate Drugs 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 3
- 229940009714 erythritol Drugs 0.000 description 3
- 235000019414 erythritol Nutrition 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 235000010492 gellan gum Nutrition 0.000 description 3
- 239000000216 gellan gum Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 3
- 239000003999 initiator Substances 0.000 description 3
- 229940119170 jojoba wax Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 239000007764 o/w emulsion Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000002540 palm oil Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 229940070721 polyacrylate Drugs 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 239000003760 tallow Substances 0.000 description 3
- 229940042585 tocopherol acetate Drugs 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 2
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 2
- 229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 description 2
- KIOWXTOCDZJCBM-UHFFFAOYSA-N 2-docosoxyethyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCOC(=O)C(C)=C KIOWXTOCDZJCBM-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- IRLPACMLTUPBCL-KQYNXXCUSA-N 5'-adenylyl sulfate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](O)[C@H]1O IRLPACMLTUPBCL-KQYNXXCUSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 239000001879 Curdlan Substances 0.000 description 2
- 229920002558 Curdlan Polymers 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical class ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- 229920002305 Schizophyllan Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- 239000001089 [(2R)-oxolan-2-yl]methanol Substances 0.000 description 2
- 125000005396 acrylic acid ester group Chemical group 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 229920006318 anionic polymer Polymers 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 2
- 229940067599 ascorbyl glucoside Drugs 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229940091509 beheneth-20 Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000019316 curdlan Nutrition 0.000 description 2
- 229940078035 curdlan Drugs 0.000 description 2
- 229940086555 cyclomethicone Drugs 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- XLLIQLLCWZCATF-UHFFFAOYSA-N ethylene glycol monomethyl ether acetate Natural products COCCOC(C)=O XLLIQLLCWZCATF-UHFFFAOYSA-N 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 2
- 229940100463 hexyl laurate Drugs 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 239000012182 japan wax Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000010550 living polymerization reaction Methods 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229940078498 peg-5 glyceryl stearate Drugs 0.000 description 2
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000010517 secondary reaction Methods 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 2
- 229940037001 sodium edetate Drugs 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 description 2
- 235000002316 solid fats Nutrition 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 239000001593 sorbitan monooleate Substances 0.000 description 2
- 229940035049 sorbitan monooleate Drugs 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 229910052714 tellurium Inorganic materials 0.000 description 2
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- SHWIJIJNPFXOFS-UHFFFAOYSA-N thiotaurine Chemical compound NCCS(O)(=O)=S SHWIJIJNPFXOFS-UHFFFAOYSA-N 0.000 description 2
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 2
- 239000002383 tung oil Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- WDQLRUYAYXDIFW-RWKIJVEZSA-N (2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-4-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 WDQLRUYAYXDIFW-RWKIJVEZSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- ORTVZLZNOYNASJ-UPHRSURJSA-N (z)-but-2-ene-1,4-diol Chemical compound OC\C=C/CO ORTVZLZNOYNASJ-UPHRSURJSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- ZWVMLYRJXORSEP-UHFFFAOYSA-N 1,2,6-Hexanetriol Chemical compound OCCCCC(O)CO ZWVMLYRJXORSEP-UHFFFAOYSA-N 0.000 description 1
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 description 1
- CUVLMZNMSPJDON-UHFFFAOYSA-N 1-(1-butoxypropan-2-yloxy)propan-2-ol Chemical compound CCCCOCC(C)OCC(C)O CUVLMZNMSPJDON-UHFFFAOYSA-N 0.000 description 1
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- GDXHBFHOEYVPED-UHFFFAOYSA-N 1-(2-butoxyethoxy)butane Chemical compound CCCCOCCOCCCC GDXHBFHOEYVPED-UHFFFAOYSA-N 0.000 description 1
- DZSVIVLGBJKQAP-UHFFFAOYSA-N 1-(2-methyl-5-propan-2-ylcyclohex-2-en-1-yl)propan-1-one Chemical compound CCC(=O)C1CC(C(C)C)CC=C1C DZSVIVLGBJKQAP-UHFFFAOYSA-N 0.000 description 1
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 1
- RRQYJINTUHWNHW-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxy)ethane Chemical compound CCOCCOCCOCC RRQYJINTUHWNHW-UHFFFAOYSA-N 0.000 description 1
- CNJRPYFBORAQAU-UHFFFAOYSA-N 1-ethoxy-2-(2-methoxyethoxy)ethane Chemical compound CCOCCOCCOC CNJRPYFBORAQAU-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- LIPRQQHINVWJCH-UHFFFAOYSA-N 1-ethoxypropan-2-yl acetate Chemical compound CCOCC(C)OC(C)=O LIPRQQHINVWJCH-UHFFFAOYSA-N 0.000 description 1
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- IFBDFMPSOCGRKA-UHFFFAOYSA-N 1-octadecoxyoctadecane;phosphoric acid Chemical compound OP(O)(O)=O.CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC IFBDFMPSOCGRKA-UHFFFAOYSA-N 0.000 description 1
- QWWTXMUURQLKOT-UHFFFAOYSA-N 1-phenoxypropan-2-yl acetate Chemical compound CC(=O)OC(C)COC1=CC=CC=C1 QWWTXMUURQLKOT-UHFFFAOYSA-N 0.000 description 1
- QQXJNLYVPPBERR-UHFFFAOYSA-N 1-phenyldecan-1-one Chemical compound CCCCCCCCCC(=O)C1=CC=CC=C1 QQXJNLYVPPBERR-UHFFFAOYSA-N 0.000 description 1
- DMFAHCVITRDZQB-UHFFFAOYSA-N 1-propoxypropan-2-yl acetate Chemical compound CCCOCC(C)OC(C)=O DMFAHCVITRDZQB-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- GQQNRZHWHWHOLI-UHFFFAOYSA-N 11-(2-decyltetradecoxymethyl)tricosane Chemical compound CCCCCCCCCCCCC(CCCCCCCCCC)COCC(CCCCCCCCCC)CCCCCCCCCCCC GQQNRZHWHWHOLI-UHFFFAOYSA-N 0.000 description 1
- PIYIOTZJXBKYSY-UHFFFAOYSA-N 11-silyloxysilyloxysilylundecanoic acid Chemical compound OC(=O)CCCCCCCCCC[SiH2]O[SiH2]O[SiH3] PIYIOTZJXBKYSY-UHFFFAOYSA-N 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- OCIQZTICBOLUJQ-UHFFFAOYSA-N 2,2,3,3-tetraethylhexanoic acid Chemical compound CCCC(CC)(CC)C(CC)(CC)C(O)=O OCIQZTICBOLUJQ-UHFFFAOYSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- RTEZXFBVXJPHKS-UHFFFAOYSA-N 2,2-dimethylpropanoic acid;2-[2-(2-hydroxypropoxy)propoxy]propan-1-ol Chemical compound CC(C)(C)C(O)=O.CC(O)COC(C)COC(C)CO RTEZXFBVXJPHKS-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- OAYXUHPQHDHDDZ-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethanol Chemical compound CCCCOCCOCCO OAYXUHPQHDHDDZ-UHFFFAOYSA-N 0.000 description 1
- VXQBJTKSVGFQOL-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethyl acetate Chemical compound CCCCOCCOCCOC(C)=O VXQBJTKSVGFQOL-UHFFFAOYSA-N 0.000 description 1
- FPZWZCWUIYYYBU-UHFFFAOYSA-N 2-(2-ethoxyethoxy)ethyl acetate Chemical compound CCOCCOCCOC(C)=O FPZWZCWUIYYYBU-UHFFFAOYSA-N 0.000 description 1
- MTVLEKBQSDTQGO-UHFFFAOYSA-N 2-(2-ethoxypropoxy)propan-1-ol Chemical compound CCOC(C)COC(C)CO MTVLEKBQSDTQGO-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- CUDYYMUUJHLCGZ-UHFFFAOYSA-N 2-(2-methoxypropoxy)propan-1-ol Chemical compound COC(C)COC(C)CO CUDYYMUUJHLCGZ-UHFFFAOYSA-N 0.000 description 1
- NCHBYORVPVDWBJ-UHFFFAOYSA-N 2-(3-methylbutoxy)ethanol Chemical compound CC(C)CCOCCO NCHBYORVPVDWBJ-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- RWLALWYNXFYRGW-UHFFFAOYSA-N 2-Ethyl-1,3-hexanediol Chemical compound CCCC(O)C(CC)CO RWLALWYNXFYRGW-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 1
- FEBUJFMRSBAMES-UHFFFAOYSA-N 2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-phosphanyloxan-4-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl phosphinite Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(OC2C(C(OP)C(O)C(CO)O2)O)C(O)C(OC2C(C(CO)OC(P)C2O)O)O1 FEBUJFMRSBAMES-UHFFFAOYSA-N 0.000 description 1
- WFSMVVDJSNMRAR-UHFFFAOYSA-N 2-[2-(2-ethoxyethoxy)ethoxy]ethanol Chemical compound CCOCCOCCOCCO WFSMVVDJSNMRAR-UHFFFAOYSA-N 0.000 description 1
- XUCVHJITBBXSMD-UHFFFAOYSA-N 2-[2-(2-hydroxyethoxy)ethoxy]ethanol;2-(2-hydroxypropoxy)propan-1-ol Chemical compound CC(O)COC(C)CO.OCCOCCOCCO XUCVHJITBBXSMD-UHFFFAOYSA-N 0.000 description 1
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 1
- LNCJHVLXANMHHD-UHFFFAOYSA-N 2-[2-heptadecyl-1-(2-hydroxyethyl)-4,5-dihydroimidazol-1-ium-1-yl]acetate Chemical compound CCCCCCCCCCCCCCCCCC1=NCC[N+]1(CCO)CC([O-])=O LNCJHVLXANMHHD-UHFFFAOYSA-N 0.000 description 1
- IKOKHHBZFDFMJW-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-(2-morpholin-4-ylethoxy)pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)OCCN1CCOCC1 IKOKHHBZFDFMJW-UHFFFAOYSA-N 0.000 description 1
- UITSPQLTFPTHJZ-UHFFFAOYSA-N 2-[[3,4,5-tris(2-hydroxyethoxy)-6-methoxyoxan-2-yl]methoxy]ethanol Chemical compound COC1OC(COCCO)C(OCCO)C(OCCO)C1OCCO UITSPQLTFPTHJZ-UHFFFAOYSA-N 0.000 description 1
- ZCOLQXXFCPFSNU-UHFFFAOYSA-N 2-[methyl(tetradecanoyl)amino]ethanesulfonic acid;sodium Chemical compound [Na].CCCCCCCCCCCCCC(=O)N(C)CCS(O)(=O)=O ZCOLQXXFCPFSNU-UHFFFAOYSA-N 0.000 description 1
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 1
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- NQBXSWAWVZHKBZ-UHFFFAOYSA-N 2-butoxyethyl acetate Chemical compound CCCCOCCOC(C)=O NQBXSWAWVZHKBZ-UHFFFAOYSA-N 0.000 description 1
- WBIQQQGBSDOWNP-UHFFFAOYSA-N 2-dodecylbenzenesulfonic acid Chemical compound CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O WBIQQQGBSDOWNP-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- SVONRAPFKPVNKG-UHFFFAOYSA-N 2-ethoxyethyl acetate Chemical compound CCOCCOC(C)=O SVONRAPFKPVNKG-UHFFFAOYSA-N 0.000 description 1
- KKDLMTFRMQVLMO-UHFFFAOYSA-N 2-heptylundecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCC)CCCCCCCCC KKDLMTFRMQVLMO-UHFFFAOYSA-N 0.000 description 1
- UPGSWASWQBLSKZ-UHFFFAOYSA-N 2-hexoxyethanol Chemical compound CCCCCCOCCO UPGSWASWQBLSKZ-UHFFFAOYSA-N 0.000 description 1
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 1
- OGJDIJKJFYOENF-UHFFFAOYSA-N 2-hexyldecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC OGJDIJKJFYOENF-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- XATHTZNVYDUDGS-UHFFFAOYSA-N 2-octadecylpropane-1,2,3-triol Chemical compound CCCCCCCCCCCCCCCCCCC(O)(CO)CO XATHTZNVYDUDGS-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- WHFKYDMBUMLWDA-UHFFFAOYSA-N 2-phenoxyethyl acetate Chemical compound CC(=O)OCCOC1=CC=CC=C1 WHFKYDMBUMLWDA-UHFFFAOYSA-N 0.000 description 1
- CUZKCNWZBXLAJX-UHFFFAOYSA-N 2-phenylmethoxyethanol Chemical compound OCCOCC1=CC=CC=C1 CUZKCNWZBXLAJX-UHFFFAOYSA-N 0.000 description 1
- HCGFUIQPSOCUHI-UHFFFAOYSA-N 2-propan-2-yloxyethanol Chemical compound CC(C)OCCO HCGFUIQPSOCUHI-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- NRWMBHYHFFGEEC-MDZDMXLPSA-N 3-[(e)-octadec-9-enoxy]propane-1,2-diol Chemical compound CCCCCCCC\C=C\CCCCCCCCOCC(O)CO NRWMBHYHFFGEEC-MDZDMXLPSA-N 0.000 description 1
- AGNTUZCMJBTHOG-UHFFFAOYSA-N 3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]propane-1,2-diol Chemical compound OCC(O)COCC(O)COCC(O)CO AGNTUZCMJBTHOG-UHFFFAOYSA-N 0.000 description 1
- GBSGXZBOFKJGMG-UHFFFAOYSA-N 3-propan-2-yloxypropan-1-ol Chemical compound CC(C)OCCCO GBSGXZBOFKJGMG-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- NDHNBHXAALUAAJ-UHFFFAOYSA-N 4,5-dimorpholin-4-yl-1h-pyridazin-6-one Chemical compound C1COCCN1C=1C(O)=NN=CC=1N1CCOCC1 NDHNBHXAALUAAJ-UHFFFAOYSA-N 0.000 description 1
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SBVKVAIECGDBTC-UHFFFAOYSA-N 4-hydroxy-2-methylidenebutanamide Chemical compound NC(=O)C(=C)CCO SBVKVAIECGDBTC-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N 5-oxoproline Chemical compound OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- MVJSIAIXMFGVSA-UHFFFAOYSA-N 6-(2-hexyldecoxy)-6-oxohexanoic acid Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCC(O)=O MVJSIAIXMFGVSA-UHFFFAOYSA-N 0.000 description 1
- LIFHMKCDDVTICL-UHFFFAOYSA-N 6-(chloromethyl)phenanthridine Chemical compound C1=CC=C2C(CCl)=NC3=CC=CC=C3C2=C1 LIFHMKCDDVTICL-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 241001479543 Mentha x piperita Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- QOQAQGZFODYYLN-UHFFFAOYSA-N OCCO.OC(=O)CCCCC(O)=O.OC(=O)CCCCC(O)=O Chemical compound OCCO.OC(=O)CCCCC(O)=O.OC(=O)CCCCC(O)=O QOQAQGZFODYYLN-UHFFFAOYSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- DJNTZVRUYMHBTD-UHFFFAOYSA-N Octyl octanoate Chemical compound CCCCCCCCOC(=O)CCCCCCC DJNTZVRUYMHBTD-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical compound OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 244000078879 Saxifraga sarmentosa Species 0.000 description 1
- 239000010404 Scutellaria baicalensis extract Substances 0.000 description 1
- 229920002197 Sodium polyaspartate Polymers 0.000 description 1
- 241000246044 Sophora flavescens Species 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N Taurine Natural products NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N Tetraethylene glycol, Natural products OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 241000488908 Torreya Species 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical class CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- LXEKPEMOWBOYRF-UHFFFAOYSA-N [2-[(1-azaniumyl-1-imino-2-methylpropan-2-yl)diazenyl]-2-methylpropanimidoyl]azanium;dichloride Chemical compound Cl.Cl.NC(=N)C(C)(C)N=NC(C)(C)C(N)=N LXEKPEMOWBOYRF-UHFFFAOYSA-N 0.000 description 1
- LDDUCKDUDZVHLN-UHFFFAOYSA-N [2-hydroxy-3-[2-hydroxy-3-(16-methylheptadecanoyloxy)propoxy]propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)COC(=O)CCCCCCCCCCCCCCC(C)C LDDUCKDUDZVHLN-UHFFFAOYSA-N 0.000 description 1
- XJXFLRWMYHIIKV-CLFAGFIQSA-N [2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[(z)-octadec-9-enoyl]oxypropoxy]propoxy]propoxy]propoxy]propoxy]propoxy]propoxy]propoxy]propoxy]propyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COC(=O)CCCCCCC\C=C/CCCCCCCC XJXFLRWMYHIIKV-CLFAGFIQSA-N 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- NPTLAYTZMHJJDP-KTKRTIGZSA-N [3-[3-[3-[3-[3-[3-[3-[3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)CO NPTLAYTZMHJJDP-KTKRTIGZSA-N 0.000 description 1
- CMPDPBDUZTUXAD-UHFFFAOYSA-N [3-hydroxy-2-(16-methylheptadecanoyloxy)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC(C)C CMPDPBDUZTUXAD-UHFFFAOYSA-N 0.000 description 1
- YDNPEEKUHZONOK-UHFFFAOYSA-M [K+].NCCS([O-])(=O)=S Chemical compound [K+].NCCS([O-])(=O)=S YDNPEEKUHZONOK-UHFFFAOYSA-M 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 229940124532 absorption promoter Drugs 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 229920000800 acrylic rubber Polymers 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 229920001586 anionic polysaccharide Polymers 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- YOQLRQUGJROXRV-UHFFFAOYSA-N benzenecarbodithioic acid;4-cyanopentanoic acid Chemical compound N#CC(C)CCC(O)=O.SC(=S)C1=CC=CC=C1 YOQLRQUGJROXRV-UHFFFAOYSA-N 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- WMNULTDOANGXRT-UHFFFAOYSA-N bis(2-ethylhexyl) butanedioate Chemical compound CCCCC(CC)COC(=O)CCC(=O)OCC(CC)CCCC WMNULTDOANGXRT-UHFFFAOYSA-N 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 1
- UGDWJDYCTNYZEU-UHFFFAOYSA-N butanedioic acid;ethane-1,2-diol Chemical compound OCCO.OC(=O)CCC(O)=O.OC(=O)CCC(O)=O UGDWJDYCTNYZEU-UHFFFAOYSA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- DKVNPHBNOWQYFE-UHFFFAOYSA-N carbamodithioic acid Chemical compound NC(S)=S DKVNPHBNOWQYFE-UHFFFAOYSA-N 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940019778 diethylene glycol diethyl ether Drugs 0.000 description 1
- 229940028356 diethylene glycol monobutyl ether Drugs 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- 229940090934 diphenylsiloxy phenyl trimethicone Drugs 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- MVFPQYVAVMINHP-UHFFFAOYSA-L disodium;octadecyl phosphate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCCCCCOP([O-])([O-])=O MVFPQYVAVMINHP-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- 239000012990 dithiocarbamate Substances 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- YRIUSKIDOIARQF-UHFFFAOYSA-N dodecyl benzenesulfonate Chemical compound CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 YRIUSKIDOIARQF-UHFFFAOYSA-N 0.000 description 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
- KWKXNDCHNDYVRT-UHFFFAOYSA-N dodecylbenzene Chemical compound CCCCCCCCCCCCC1=CC=CC=C1 KWKXNDCHNDYVRT-UHFFFAOYSA-N 0.000 description 1
- 229940071161 dodecylbenzenesulfonate Drugs 0.000 description 1
- 229940060296 dodecylbenzenesulfonic acid Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940059402 eriobotrya japonica leaf extract Drugs 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 229960005082 etohexadiol Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 229940072117 fennel extract Drugs 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 210000000003 hoof Anatomy 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229940035429 isobutyl alcohol Drugs 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 238000010551 living anionic polymerization reaction Methods 0.000 description 1
- 238000010552 living cationic polymerization reaction Methods 0.000 description 1
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000001771 mentha piperita Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- SINFYWWJOCXYFD-UHFFFAOYSA-N methoxymethyl prop-2-enoate Chemical compound COCOC(=O)C=C SINFYWWJOCXYFD-UHFFFAOYSA-N 0.000 description 1
- 229940100485 methyl gluceth-10 Drugs 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 1
- ZQXSMRAEXCEDJD-UHFFFAOYSA-N n-ethenylformamide Chemical class C=CNC=O ZQXSMRAEXCEDJD-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- WWDHABCVIVMHKP-UHFFFAOYSA-N nonyl nonanoate Chemical compound CCCCCCCCCOC(=O)CCCCCCCC WWDHABCVIVMHKP-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- UVPGECJLXBGLDW-UHFFFAOYSA-N octadecan-7-ol Chemical compound CCCCCCCCCCCC(O)CCCCCC UVPGECJLXBGLDW-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- JCGNDDUYTRNOFT-UHFFFAOYSA-N oxolane-2,4-dione Chemical compound O=C1COC(=O)C1 JCGNDDUYTRNOFT-UHFFFAOYSA-N 0.000 description 1
- 239000012186 ozocerite Substances 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920003175 pectinic acid Polymers 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229960003424 phenylacetic acid Drugs 0.000 description 1
- 239000003279 phenylacetic acid Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 229940105297 polyglyceryl-2 diisostearate Drugs 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 229940114930 potassium stearate Drugs 0.000 description 1
- YRJKYHIIYRGTCC-UHFFFAOYSA-M potassium;2-hydroxy-4-methoxybenzoate Chemical compound [K+].COC1=CC=C(C([O-])=O)C(O)=C1 YRJKYHIIYRGTCC-UHFFFAOYSA-M 0.000 description 1
- FYFUQDOEHQSBFN-UHFFFAOYSA-M potassium;docosanoate Chemical compound [K+].CCCCCCCCCCCCCCCCCCCCCC([O-])=O FYFUQDOEHQSBFN-UHFFFAOYSA-M 0.000 description 1
- ANBFRLKBEIFNQU-UHFFFAOYSA-M potassium;octadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCCCC([O-])=O ANBFRLKBEIFNQU-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000001651 pyrus cydonia seed extract Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- NRWMBHYHFFGEEC-UHFFFAOYSA-N selachyl alcohol Natural products CCCCCCCCC=CCCCCCCCCOCC(O)CO NRWMBHYHFFGEEC-UHFFFAOYSA-N 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 1
- 229940045898 sodium stearoyl glutamate Drugs 0.000 description 1
- KDHFCTLPQJQDQI-BDQAORGHSA-M sodium;(4s)-4-amino-5-octadecanoyloxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC([O-])=O KDHFCTLPQJQDQI-BDQAORGHSA-M 0.000 description 1
- UKSFMDODPANKJI-UHFFFAOYSA-M sodium;2-[methyl(octadecanoyl)amino]ethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)N(C)CCS([O-])(=O)=O UKSFMDODPANKJI-UHFFFAOYSA-M 0.000 description 1
- QKHBMQWPOUUMQZ-BDQAORGHSA-M sodium;hydron;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC([O-])=O QKHBMQWPOUUMQZ-BDQAORGHSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940033331 soy sterol Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- JLGLQAWTXXGVEM-UHFFFAOYSA-N triethylene glycol monomethyl ether Chemical compound COCCOCCOCCO JLGLQAWTXXGVEM-UHFFFAOYSA-N 0.000 description 1
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- SVETUDAIEHYIKZ-IUPFWZBJSA-N tris[(z)-octadec-9-enyl] phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCCOP(=O)(OCCCCCCCC\C=C/CCCCCCCC)OCCCCCCCC\C=C/CCCCCCCC SVETUDAIEHYIKZ-IUPFWZBJSA-N 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60K—ARRANGEMENT OR MOUNTING OF PROPULSION UNITS OR OF TRANSMISSIONS IN VEHICLES; ARRANGEMENT OR MOUNTING OF PLURAL DIVERSE PRIME-MOVERS IN VEHICLES; AUXILIARY DRIVES FOR VEHICLES; INSTRUMENTATION OR DASHBOARDS FOR VEHICLES; ARRANGEMENTS IN CONNECTION WITH COOLING, AIR INTAKE, GAS EXHAUST OR FUEL SUPPLY OF PROPULSION UNITS IN VEHICLES
- B60K6/00—Arrangement or mounting of plural diverse prime-movers for mutual or common propulsion, e.g. hybrid propulsion systems comprising electric motors and internal combustion engines ; Control systems therefor, i.e. systems controlling two or more prime movers, or controlling one of these prime movers and any of the transmission, drive or drive units
- B60K6/20—Arrangement or mounting of plural diverse prime-movers for mutual or common propulsion, e.g. hybrid propulsion systems comprising electric motors and internal combustion engines ; Control systems therefor, i.e. systems controlling two or more prime movers, or controlling one of these prime movers and any of the transmission, drive or drive units the prime-movers consisting of electric motors and internal combustion engines, e.g. HEVs
- B60K6/42—Arrangement or mounting of plural diverse prime-movers for mutual or common propulsion, e.g. hybrid propulsion systems comprising electric motors and internal combustion engines ; Control systems therefor, i.e. systems controlling two or more prime movers, or controlling one of these prime movers and any of the transmission, drive or drive units the prime-movers consisting of electric motors and internal combustion engines, e.g. HEVs characterised by the architecture of the hybrid electric vehicle
- B60K6/44—Series-parallel type
- B60K6/445—Differential gearing distribution type
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60W—CONJOINT CONTROL OF VEHICLE SUB-UNITS OF DIFFERENT TYPE OR DIFFERENT FUNCTION; CONTROL SYSTEMS SPECIALLY ADAPTED FOR HYBRID VEHICLES; ROAD VEHICLE DRIVE CONTROL SYSTEMS FOR PURPOSES NOT RELATED TO THE CONTROL OF A PARTICULAR SUB-UNIT
- B60W20/00—Control systems specially adapted for hybrid vehicles
- B60W20/10—Controlling the power contribution of each of the prime movers to meet required power demand
- B60W20/12—Controlling the power contribution of each of the prime movers to meet required power demand using control strategies taking into account route information
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60W—CONJOINT CONTROL OF VEHICLE SUB-UNITS OF DIFFERENT TYPE OR DIFFERENT FUNCTION; CONTROL SYSTEMS SPECIALLY ADAPTED FOR HYBRID VEHICLES; ROAD VEHICLE DRIVE CONTROL SYSTEMS FOR PURPOSES NOT RELATED TO THE CONTROL OF A PARTICULAR SUB-UNIT
- B60W10/00—Conjoint control of vehicle sub-units of different type or different function
- B60W10/04—Conjoint control of vehicle sub-units of different type or different function including control of propulsion units
- B60W10/06—Conjoint control of vehicle sub-units of different type or different function including control of propulsion units including control of combustion engines
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60W—CONJOINT CONTROL OF VEHICLE SUB-UNITS OF DIFFERENT TYPE OR DIFFERENT FUNCTION; CONTROL SYSTEMS SPECIALLY ADAPTED FOR HYBRID VEHICLES; ROAD VEHICLE DRIVE CONTROL SYSTEMS FOR PURPOSES NOT RELATED TO THE CONTROL OF A PARTICULAR SUB-UNIT
- B60W10/00—Conjoint control of vehicle sub-units of different type or different function
- B60W10/04—Conjoint control of vehicle sub-units of different type or different function including control of propulsion units
- B60W10/08—Conjoint control of vehicle sub-units of different type or different function including control of propulsion units including control of electric propulsion units, e.g. motors or generators
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60W—CONJOINT CONTROL OF VEHICLE SUB-UNITS OF DIFFERENT TYPE OR DIFFERENT FUNCTION; CONTROL SYSTEMS SPECIALLY ADAPTED FOR HYBRID VEHICLES; ROAD VEHICLE DRIVE CONTROL SYSTEMS FOR PURPOSES NOT RELATED TO THE CONTROL OF A PARTICULAR SUB-UNIT
- B60W20/00—Control systems specially adapted for hybrid vehicles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60W—CONJOINT CONTROL OF VEHICLE SUB-UNITS OF DIFFERENT TYPE OR DIFFERENT FUNCTION; CONTROL SYSTEMS SPECIALLY ADAPTED FOR HYBRID VEHICLES; ROAD VEHICLE DRIVE CONTROL SYSTEMS FOR PURPOSES NOT RELATED TO THE CONTROL OF A PARTICULAR SUB-UNIT
- B60W20/00—Control systems specially adapted for hybrid vehicles
- B60W20/10—Controlling the power contribution of each of the prime movers to meet required power demand
- B60W20/13—Controlling the power contribution of each of the prime movers to meet required power demand in order to stay within battery power input or output limits; in order to prevent overcharging or battery depletion
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60W—CONJOINT CONTROL OF VEHICLE SUB-UNITS OF DIFFERENT TYPE OR DIFFERENT FUNCTION; CONTROL SYSTEMS SPECIALLY ADAPTED FOR HYBRID VEHICLES; ROAD VEHICLE DRIVE CONTROL SYSTEMS FOR PURPOSES NOT RELATED TO THE CONTROL OF A PARTICULAR SUB-UNIT
- B60W20/00—Control systems specially adapted for hybrid vehicles
- B60W20/10—Controlling the power contribution of each of the prime movers to meet required power demand
- B60W20/15—Control strategies specially adapted for achieving a particular effect
- B60W20/16—Control strategies specially adapted for achieving a particular effect for reducing engine exhaust emissions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60W—CONJOINT CONTROL OF VEHICLE SUB-UNITS OF DIFFERENT TYPE OR DIFFERENT FUNCTION; CONTROL SYSTEMS SPECIALLY ADAPTED FOR HYBRID VEHICLES; ROAD VEHICLE DRIVE CONTROL SYSTEMS FOR PURPOSES NOT RELATED TO THE CONTROL OF A PARTICULAR SUB-UNIT
- B60W20/00—Control systems specially adapted for hybrid vehicles
- B60W20/20—Control strategies involving selection of hybrid configuration, e.g. selection between series or parallel configuration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60W—CONJOINT CONTROL OF VEHICLE SUB-UNITS OF DIFFERENT TYPE OR DIFFERENT FUNCTION; CONTROL SYSTEMS SPECIALLY ADAPTED FOR HYBRID VEHICLES; ROAD VEHICLE DRIVE CONTROL SYSTEMS FOR PURPOSES NOT RELATED TO THE CONTROL OF A PARTICULAR SUB-UNIT
- B60W20/00—Control systems specially adapted for hybrid vehicles
- B60W20/40—Controlling the engagement or disengagement of prime movers, e.g. for transition between prime movers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60W—CONJOINT CONTROL OF VEHICLE SUB-UNITS OF DIFFERENT TYPE OR DIFFERENT FUNCTION; CONTROL SYSTEMS SPECIALLY ADAPTED FOR HYBRID VEHICLES; ROAD VEHICLE DRIVE CONTROL SYSTEMS FOR PURPOSES NOT RELATED TO THE CONTROL OF A PARTICULAR SUB-UNIT
- B60W30/00—Purposes of road vehicle drive control systems not related to the control of a particular sub-unit, e.g. of systems using conjoint control of vehicle sub-units
- B60W30/18—Propelling the vehicle
- B60W30/182—Selecting between different operative modes, e.g. comfort and performance modes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60W—CONJOINT CONTROL OF VEHICLE SUB-UNITS OF DIFFERENT TYPE OR DIFFERENT FUNCTION; CONTROL SYSTEMS SPECIALLY ADAPTED FOR HYBRID VEHICLES; ROAD VEHICLE DRIVE CONTROL SYSTEMS FOR PURPOSES NOT RELATED TO THE CONTROL OF A PARTICULAR SUB-UNIT
- B60W30/00—Purposes of road vehicle drive control systems not related to the control of a particular sub-unit, e.g. of systems using conjoint control of vehicle sub-units
- B60W30/18—Propelling the vehicle
- B60W30/188—Controlling power parameters of the driveline, e.g. determining the required power
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60W—CONJOINT CONTROL OF VEHICLE SUB-UNITS OF DIFFERENT TYPE OR DIFFERENT FUNCTION; CONTROL SYSTEMS SPECIALLY ADAPTED FOR HYBRID VEHICLES; ROAD VEHICLE DRIVE CONTROL SYSTEMS FOR PURPOSES NOT RELATED TO THE CONTROL OF A PARTICULAR SUB-UNIT
- B60W30/00—Purposes of road vehicle drive control systems not related to the control of a particular sub-unit, e.g. of systems using conjoint control of vehicle sub-units
- B60W30/18—Propelling the vehicle
- B60W30/188—Controlling power parameters of the driveline, e.g. determining the required power
- B60W30/1882—Controlling power parameters of the driveline, e.g. determining the required power characterised by the working point of the engine, e.g. by using engine output chart
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60W—CONJOINT CONTROL OF VEHICLE SUB-UNITS OF DIFFERENT TYPE OR DIFFERENT FUNCTION; CONTROL SYSTEMS SPECIALLY ADAPTED FOR HYBRID VEHICLES; ROAD VEHICLE DRIVE CONTROL SYSTEMS FOR PURPOSES NOT RELATED TO THE CONTROL OF A PARTICULAR SUB-UNIT
- B60W40/00—Estimation or calculation of non-directly measurable driving parameters for road vehicle drive control systems not related to the control of a particular sub unit, e.g. by using mathematical models
- B60W40/10—Estimation or calculation of non-directly measurable driving parameters for road vehicle drive control systems not related to the control of a particular sub unit, e.g. by using mathematical models related to vehicle motion
- B60W40/105—Speed
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F20/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
- C08F20/02—Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
- C08F20/04—Acids, Metal salts or ammonium salts thereof
- C08F20/06—Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60W—CONJOINT CONTROL OF VEHICLE SUB-UNITS OF DIFFERENT TYPE OR DIFFERENT FUNCTION; CONTROL SYSTEMS SPECIALLY ADAPTED FOR HYBRID VEHICLES; ROAD VEHICLE DRIVE CONTROL SYSTEMS FOR PURPOSES NOT RELATED TO THE CONTROL OF A PARTICULAR SUB-UNIT
- B60W2552/00—Input parameters relating to infrastructure
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60W—CONJOINT CONTROL OF VEHICLE SUB-UNITS OF DIFFERENT TYPE OR DIFFERENT FUNCTION; CONTROL SYSTEMS SPECIALLY ADAPTED FOR HYBRID VEHICLES; ROAD VEHICLE DRIVE CONTROL SYSTEMS FOR PURPOSES NOT RELATED TO THE CONTROL OF A PARTICULAR SUB-UNIT
- B60W2556/00—Input parameters relating to data
- B60W2556/45—External transmission of data to or from the vehicle
- B60W2556/50—External transmission of data to or from the vehicle of positioning data, e.g. GPS [Global Positioning System] data
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02T—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO TRANSPORTATION
- Y02T10/00—Road transport of goods or passengers
- Y02T10/10—Internal combustion engine [ICE] based vehicles
- Y02T10/40—Engine management systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02T—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO TRANSPORTATION
- Y02T10/00—Road transport of goods or passengers
- Y02T10/60—Other road transportation technologies with climate change mitigation effect
- Y02T10/62—Hybrid vehicles
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02T—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO TRANSPORTATION
- Y02T10/00—Road transport of goods or passengers
- Y02T10/60—Other road transportation technologies with climate change mitigation effect
- Y02T10/72—Electric energy management in electromobility
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02T—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO TRANSPORTATION
- Y02T10/00—Road transport of goods or passengers
- Y02T10/80—Technologies aiming to reduce greenhouse gasses emissions common to all road transportation technologies
- Y02T10/84—Data processing systems or methods, management, administration
Definitions
- FIG. 1 A first figure.
- the present invention relates to a cosmetic, and more specifically to a cosmetic blended with a precisely synthesized polymer.
- Freshness, good spreadability, and non-stickiness are properties desired to many cosmetics, but it is not easy to exhibit rich feeling and full-bodied feeling without impairing these properties.
- Patent Literature 1 It is generally known that rich feeling of cosmetics correlates with the viscoelastic ratio thereof, and full-bodied feeling can be evaluated with the gradient of the first normal stress difference.
- the viscoelastic ratio and the gradient of the first normal stress difference of cosmetics greatly depend on blending of thickeners.
- thickeners commonly used in cosmetics include anionic polymers and polysaccharides.
- anionic polymers absorb water, they gelate and exhibit a thickening effect; however, it is difficult to exhibit rich feeling and full-bodied feeling when blended in large amounts and, stringiness (thread-forming property), which is undesirable for cosmetics, tends occur.
- polysaccharides have a problem of causing stickiness when blended in large amounts since they do not penetrate the skin and remain on the skin.
- the present invention was made in view of the above-described problems in conventional art, and an object of the present invention is to provide a cosmetic that is excellent in rich feeling and full-bodied feeling, does not have stringiness, and is also excellent in freshness, spreadability, and non-stickiness.
- the present inventors have been working on the development of thickeners that are suitable for cosmetics, and have reported that “polyacrylic acid or a salt thereof or poly(2-acrylamido-2-methylpropanesulfonic acid) or a salt thereof that has the weight-average molecular weight of 500,000 to 8,000,000, has the content of molecular species having the molecular weight of 10,000,000 or more of 10% by mass or less; and is linear” can be used as a thickener capable of providing a thickening effect to cosmetics without imparting stringiness (Patent Literature 2).
- the present inventors have diligently studied the above-described problems. As a result, they have found that when the “polyacrylic acid or a salt thereof or poly(2-acrylamido-2-methylpropanesulfonic acid) or a salt thereof” is added to an aqueous phase in which a commonly used thickener is dissolved, the viscoelastic ratio and the gradient of the first linear stress difference increase synergistically, and significant rich feeling and full-bodied feeling can be exhibited. Moreover, the present inventors have found that a cosmetic prepared by using said thickener in combination has excellent rich feeling and full-bodied feeling, does not have stringiness, and also has excellent freshness, spreadability, and non-stickiness, and thus completed the present invention.
- the present invention encompasses the following.
- a cosmetic comprising components (a) and (b):
- the crosslinked water-swellable polymer of the component (b) is one or more selected from the group consisting of a carboxyvinyl polymer, acrylamidealkylsulfonic acid/beheneth-25 crosslinked copolymer, acrylamidealkylsulfonic acid/vinylpyrrolidone crosslinked copolymer and acrylamidealkylsulfonic acid/alkylacrylamide crosslinked copolymer.
- the present invention provides a cosmetic that is excellent in rich feeling and full-bodied feeling, does not have stringiness, and also excellent in freshness, spreadability, and non-stickiness.
- FIG. 1 is a graph showing the results of analyzing the viscoelastic ratio, which is an index of rich feeling, and the gradient of the first normal stress difference, which is an index of full-bodied feeling, of the thickeners used in the Examples of the present application.
- the “linear polymer having a weight-average molecular weight of 500,000 to 8,000,000 and a thread length of 10 mm or less at room temperature when formed into a 1% by mass solution” may be referred to as a “precisely synthesized polymer”.
- the “thread length” is a value measured by the method described in Patent Literature 2. Namely, a value defined as “a distance determined by putting a round disk having a diameter of about 1 cm uniformly and lightly into contact with a surface of the solution, lowering a container at the velocity of 5 mm/sec, and measuring the distance that the container descended until a thread of the solution is cut”.
- the “content of molecular species having the molecular weight of 10,000,000 or more” is usually “10% by mass or less”, and thus the requirement of “the content of molecular species having a molecular weight of 10,000,000 or more is 10% by mass or less” may be optional.
- Polyacrylic acid and poly(2-acrylamido-2-methylpropanesulfonic acid) having the properties of the precisely synthesized polymer may be referred to as “precisely synthesized polyacrylic acid” and “precisely synthesized PAMPS,” respectively.
- PAMPS is an abbreviation for poly(2-acrylamido-2-methylpropanesulfonic acid).
- the content of the compound having the molecular weight that is three times or more of the weight-average molecular weight may be 10% by mass or less. This is because the stringiness of the precisely synthesized polymer tends to be reduced more.
- polyacrylic acid or a salt thereof or poly(2-acrylamido-2-methylpropanesulfonic acid) or a salt thereof that has a weight-average molecular weight of 500,000 to 8,000,000, has a thread length of 10 mm or less at room temperature when formed into a 1% by mass solution, and is linear can be used as the component (a).
- the precisely synthesized polyacrylic acid or a salt thereof or the precisely synthesized PAMPS or a salt thereof can be used as the component (a).
- alkali metal salts for example, sodium salt, potassium salt, magnesium salt, calcium salt, etc.
- organic amine salts for example, monoethanolamine salt, diethanolamine salt, triethanolamine salt, triisopropanolamine salt, etc.
- the salts of basic nitrogen-containing compounds such as 2-amino-2-methyl-1-propanol, 2-amino-2-methyl-1,3-propanediol, 2-amino-2-hydroxymethyl-1,3-propanediol, L-arginine, L-lysine, and L-alkyl taurine, etc.
- monovalent alkali metal salts and organic amine salts are preferred, a sodium salt, potassium salt and triethanolamine salt are more preferred, and a sodium salt is the most preferred.
- the polyacrylic acid salt or PAMPS salt indicates a compound obtained by neutralizing the polyacrylic acid or PAMPS with the above-described base (namely, the above-described alkali metals, organic amines, basic nitrogen-containing compounds, etc.) or a compound obtained by polymerizing the acrylic acid or 2-acrylamide-2-methylpropanesulfonic acid (hereinafter abbreviated as AMPS) whose acid section is neutralized in advance with the above-described base.
- the above-described base namely, the above-described alkali metals, organic amines, basic nitrogen-containing compounds, etc.
- AMPS 2-acrylamide-2-methylpropanesulfonic acid
- the precisely synthesized polymers those that can be synthesized by a RAFT polymerization method to be described later are preferable.
- examples include homopolymers and/or salts thereof in which acrylic acid monomers such as methacrylic acid, alkyl acrylates, alkyl methacrylates, acrylic acid esters; acrylamide monomers such as acrylamide and dimethylacrylamide; vinyl monomers such as vinyl alcohol, vinylpyrrolidone, vinyl acetate, carboxyvinyl, and vinyl methyl ether; and styrene, urethane, etc. are the constituent unit monomer; and copolymers and/or salts thereof consisting of two kinds or more of the monomers selected from these monomers, acrylic acid, and AMPS.
- constituent unit is an acrylic acid monomer or acrylamide monomer
- constituent unit is an acrylic acid monomer or acrylamide monomer
- macro-monomers in which polyethylene glycol, silicone-based polymer compound, etc. are added to the above-described monomer, as the side chain, can also suitably be used as the constituent unit.
- the compound examples include polyacrylamide, polydimethylacrylamide, polyvinyl alcohol, polyvinylpyrrolidone, polyvinylmethyl ether, polyvinyl acetate, carboxyvinyl polymer, etc.; and (acrylic acid/alkyl acrylate) copolymer, (acrylic acid/alkyl methacrylate) copolymer, (alkyl acrylate/styrene) copolymer, polyacrylic acid ester copolymer, (dimethylacrylamide/2-acrylamido-2-methylpropanesulfonic acid) copolymer and salts thereof.
- the amount of the component (a) blended in the cosmetic according to the present invention is 0.005 to 2% by mass, preferably 0.005 to 1.5% by mass, and more preferably 0.005 to 1% by mass.
- the blending amount is less than 0.005% by mass, a sufficient normal stress may not be achieved, and when the blending amount exceeds 2% by mass, the normal stress may be too high and cause a slimy texture.
- the precisely synthesized polymer of the present invention can be synthesized by a publicly known living polymerization method.
- living polymerization include living anionic polymerization, living cationic polymerization, living radical polymerization (precise radical polymerization, or controlled radical polymerization), etc.
- Examples of living radical polymerization include (radical) polymerization that is mediated by nitroxide, or nitroxide-mediated (radical) polymerization (NLRP), atom transfer radical polymerization (ATRP), reversible addition-fragmentation chain transfer (RAFT) polymerization, etc.
- Examples of atom transfer radical polymerization (ATRP) include electron transfer generated activator ATRP, or activators generated by electron transfer ATRP (AGET ATRP), electron transfer regenerated activator ATRP, or activators regenerated by electron transfer ATRP (ARGET ATRP), initiators to continuously regenerate active species ATRP, or initiators for continuous activator regeneration ATRP (ICAR ATRP), and reverse ATRP (Reverse ATRP).
- the RAFT polymerization method is a living radical polymerization method that uses a RAFT agent as a chain transfer agent.
- a derivative technology of the RAFT polymerization include living radical polymerization in which organic tellurium is the growing end, or organic tellurium-mediated living radical polymerization (TERP), antimony-mediated living radical polymerization (SBRP), and bismuth-mediated living radical polymerization (BIRP), etc.
- other living radical polymerizations include iodine transfer radical polymerization (IRP), cobalt-mediated radical polymerization (CMRP), etc.
- the direct polymerization of acrylic acid is preferable because of the simplicity of polymerization.
- protected acrylic acid esters such as t-butyl acrylate, methoxymethyl acrylate, and methyl acrylate are used, and the desired polymer compound can be obtained by the succeeding deprotection.
- the living radical polymerization method is preferable because the precision synthesis of a high molecular weight body (namely, the synthesis of polymer compounds with narrow molecular weight distribution) is possible, and the reversible addition-fragmentation chain transfer polymerization method (RAFT polymerization method) is more preferable (Patent Literature 2).
- RAFT polymerization method reversible addition-fragmentation chain transfer polymerization method
- the RAFT polymerization method is a polymerization method in which growth continues while exchanging a chain transfer agent (a RAFT agent) between active polymer ends; namely, living is achieved by a so-called exchange chain mechanism.
- a chain transfer agent a RAFT agent
- the RAFT agent bonds to a growth end of the polymer chain, it becomes a resting state (dormant state); and when the RAFT agent is detached, a growth reaction occurs.
- the equilibrium state of bonding is significantly biased toward the bonding side (i.e., the time when the RAFT agent is bonded is much longer than the time when the RAFT agent is detached), the growth rate of the polymer chain is very slow, and the reactivity of the end can be suppressed.
- the rate of the growing reaction in each polymer chain becomes the same, and the degree of polymerization of the polymer is basically proportional to the reaction time, a polymer having an extremely narrow molecular weight distribution can be obtained. Moreover, since the reactivity is low, it is considered that secondary reactions such as branching and crosslinking does not occur easily.
- a dithiocarbonyl compound and a trithiocarbonyl compound can be preferably used as RAFT agents (i.e., chain transfer agents).
- Dithiocarbamate and trithiocarbamate are more preferred, and 4-cyanopentanoic acid dithiobenzoate and ⁇ -(methyltrithiocarbonate)-S-phenylacetic acid are most preferred.
- the polymerization initiator that has a similar chemical structure as that of the chain transfer agent is preferred, and an azo initiator is preferred.
- the polymerization solvent is not limited in particular, and those having high solubility of monomers and polymers are suitably selected.
- the polymerization time is preferably several hours to 100 hours.
- the molecular weight of the precisely synthesized polymer can be measured by publicly known methods, such as a light scattering method, an ultracentrifugal method, and a chromatographic method for the weight-average molecular weight; and an osmometric method and a chromatographic method for the number-average molecular weight.
- the chromatographic method is preferred because the weight-average molecular weight, the number-average molecular weight, and the molecular weight distribution can easily be obtained with a small amount of sample; in particular, a gel permeation chromatographic method (hereinafter abbreviated as GPC) is preferred.
- GPC gel permeation chromatographic method
- the molecular weight distribution used in this application is the value determined by dividing the weight-average molecular weight obtained by GPC analysis by the number-average molecular weight.
- (b) a crosslinked water-swellable polymer having a crosslinking density of 0.01 to 1 mol %, or a microgel obtained by crushing a gel consisting of a hydrophilic compound having gelation ability can be used as the component (b).
- the crosslinked water-swellable polymer may be a polymer based on (meth)acrylic acid or modified (meth)acrylic acid.
- examples thereof include, but not limited to: crosslinked polymers of acrylic acid represented by a carboxyvinyl polymer (a carbomer), copolymers of (meth)acrylic acid and polyalkylene polyether, hydrophobically modified poly(meth)acrylates, (meth)acrylate/C10-30 alkyl acrylate polymers, (meth)acrylates/beheneth-25 methacrylate copolymers, (meth)acrylate/(meth)acrylamide copolymers, (meth)acrylate/(meth)alkylacrylamide copolymers, (meth)acrylate/(meth)hydroxyethylacrylamide copolymers, and (meth)acrylate/polyalkyleneoxide alkyl-modified (meth)acrylates.
- a carboxyvinyl polymer an acrylamidoalkylsulfonic acid/beheneth-25 crosslinked copolymer, an acrylamidoalkylsulfonic acid/vinylpyrrolidone crosslinked copolymer, and an acrylamidoalkylsulfonic acid/alkylacrylamide crosslinked copolymer are particularly preferable.
- the crosslinking density of the crosslinked water-swellable polymer is 0.01 to 1 mol %, preferably 0.02 to 0.8 mol %, and most preferably 0.05 to 0.5 mol %.
- a polymer capable of infinitely swelling with water is not suitable.
- microgel examples include a microgel obtained by dissolving a hydrophilic compound having gelation ability in water or an aqueous component, leaving the solution to cool to form a gel, and crushing the formed gel.
- the hydrophilic compound having gelation ability is not particularly limited, so long as it is a water-soluble compound having gelation ability and is used in the cosmetic and pharmaceutical fields.
- Specific examples include, but not limited to, hydrophilic proteins having gelation ability such as gelatin and collagen, and hydrophilic polysaccharides such as agar, curdlan, scleroglucan, schizophyllan, gellan gum, alginic acid, carrageenan, mannan, pectin, and hyaluronic acid.
- gelatin, agar, curdlan, gellan gum, alginic acid, and carrageenan can be used preferably because they are not easily affected by salts and ions, and are capable of forming a stable gel.
- One of or two or more of the hydrophilic compounds having gelation ability can be used.
- the microgel according to the present invention can be produced by the method disclosed in Japanese Patent No. 4979095 B, for example. Specifically, after the hydrophilic compound having gelation ability is dissolved in water or an aqueous component, it is left to cool and solidified to form a gel.
- the compound can be dissolved in water or an aqueous component by mixing, heating, or the like. Gelation (solidification) may be carried out by stopping the heating after dissolution and leaving the solution to stand (to stand still) until the temperature is lower than the gelation temperature (solidification temperature).
- the formed gel is processed with a homogenizer, disper, mechanical stirrer, or the like to crush the formed gel and obtain the desired microgel.
- the average particle size of the microgel is preferably 0.1 to 1,000 ⁇ m, more preferably about 1 to 300 ⁇ m, and even more preferably about 10 to 200 ⁇ m.
- the amount of the crosslinked water-swellable polymer having a crosslinking density of 0.01 to 1 mol % blended in the cosmetic of the present invention is 0.01 to 2% by mass, preferably 0.02 to 1.5% by mass, and more preferably 0.05 to 1% by mass.
- the blending amount is less than 0.01% by mass, a sufficient thickening effect may not be achieved.
- the blending amount exceeds 5% by mass, stickiness may occur.
- the amount of the microgel obtained by crushing a gel, which is formed of a hydrophilic compound having gelation ability, blended in the cosmetic of the present invention is 0.1 to 5% by mass, preferably 0.15 to 4% by mass, and more preferably 0.2 to 3% by mass. When the amount is less than 0.1% by mass, a sufficient gelation ability may not be achieved. When the blending amount exceeds 5% by mass, a rough texture may occur.
- the oil component that forms the oil phase of the cosmetic according to the present invention can be selected from oil components conventionally used in cosmetics and the like, and is not particularly limited.
- the oil component may be one or two or more selected from hydrocarbon oils, higher fatty acids, higher alcohols, synthetic ester oils, silicone oils, liquid fats and oils, solid fats and oils, waxes, oil-soluble drugs, and the like.
- hydrocarbon oils include, but not limited to, isododecane, isohexadecane, isoparaffin, liquid paraffin, ozocerite, squalane, pristane, paraffin, ceresin, squalene, vaseline, and microcrystalline wax.
- higher fatty acids include, but not limited to, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, undecylenic acid, tallic acid, isostearic acid, linoleic acid, linolenic acid, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA).
- higher alcohols include, but not limited to: linear alcohols (such as lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, and cetostearyl alcohol); and branched-chain alcohols (such as monostearylglycerin ether (batyl alcohol)-2-decyltetradecinol, lanolin alcohol, cholesterol, phytosterol, hexyldodecanol, isostearyl alcohol, and octyldodecanol).
- linear alcohols such as lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, and cetostearyl alcohol
- branched-chain alcohols such as monostearylglycerin ether (batyl alcohol)-2-decyltetradecinol, lanolin alcohol, cholesterol, phytosterol, hexyldodecanol, is
- ester oils include, but not limited to, octyl octanoate, nonyl nonanoate, cetyl octanoate, isopropyl myristate, octyl dodecyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, myristyl myristate, decyl oleate, hexyl decyl dimethyloctanoate, cetyl lactate, myristyl lactate, lanolin acetate, isocetyl stearate, isocetyl isostearate, cholesteryl 12-hydroxystearate, ethylene glycol di-2-ethylhexanoate, dipentaerythritol fatty acid ester, N-alkylene glycol monoisostearate, neopentyl glycol dicaprate, tripropylene glycol pivalate, diis
- silicone oils include, but not limited to, chain polysiloxanes (e.g., dimethylpolysiloxane, methylphenyl polysiloxane, diphenyl polysiloxane, etc.), ring polysiloxanes (e.g., octamethylcyclotetrasiloxane, decamethyl cyclopenta siloxane, dodecamethyl cyclohexa siloxane, etc.), silicone resins forming a three-dimensional network structure, silicone rubbers, various modified polysiloxanes (amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, fluorine-modified polysiloxane, etc.), and acryl silicones.
- chain polysiloxanes e.g., dimethylpolysiloxane, methylphenyl polysiloxane, diphenyl polysiloxane, etc
- liquid fats include, but not limited to, avocado oil, camellia oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, par chic oil, wheat germ oil, southern piece oil, castor oil, linseed oil, safflower oil, cotton seed oil, perilla oil, soybean oil, groundnut oil, brown real oil, torreya oil, rice bran oil, Chinese tung oil, Japanese tung oil, jojoba oil, germ oil, and triglycerol.
- solid fats include, but not limited to, cacao butter, coconut oil, horse fat, hydrogenated coconut oil, palm oil, beef tallow, sheep tallow, hydrogenated beef tallow, palm kernel oil, lard, beef bones fat, Japan wax kernel oil, hardened oil, hoof oil, Japan wax, and hydrogenated caster oil.
- waxes include, but not limited to, beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, insect wax, spermaceti, montan wax, bran wax, lanolin, kapok wax, lanolin acetate, liquid lanolin, sugarcane wax, lanolin fatty acid isopropyl ester, hexyl laurate, reduced lanolin, jojoba wax, hardened lanolin, shellac wax, POE lanolin alcohol ether, POE lanolin alcohol acetate, POE cholesterol ether, lanolin fatty acid polyethylene glycol, and POE hydrogenated lanolin alcohol ether.
- the oil phase of the oil-in-water emulsion cosmetic according to the present invention may contain oily components commonly used in cosmetics within the range of not adversely affecting the effect of the present invention.
- various surfactants and/or emulsifiers can be used alone or in combination as an emulsifier.
- a surfactant can be suitably selected from nonionic surfactants, cationic surfactants, anionic surfactants, and amphoteric surfactants, and it is preferable that the overall HLB becomes 7 or more.
- the HLB is an index indicating a balance between hydrophilicity and lypophilicity (a hydrophilic-lypophilic balance). In the present invention, it is a value calculated by the following equation of Oda and Teramura, et al.
- HLB ( ⁇ inorganic value/ ⁇ organic value) ⁇ 10
- POE polyoxyethylene
- POP polyoxypropylene
- nonionic surfactants include, but not limited to: POE sorbitan fatty acid esters such as POE-sorbitan monostearate, POE-sorbitan monooleate, and POE-sorbitan tetraoleate; POE sorbit fatty acid esters such as POE-sorbit monooleate, POE-sorbit pentaoleate, and POE-sorbit monostearate; POE glycerin fatty acid esters such as POE-glycerin monostearate, POE-glycerin monoisostearate, and POE-glycerin triisostearate; POE fatty acid esters such as POE-monooleate, POE-distearate, POE-monodioleate, and ethylene glycol stearate; POE alkyl ethers such as POE-lauryl ether, POE-oleyl ether, POE-stearyl ether, POE-behenyl
- anionic surfactants include, but not limited to: higher fatty acid salts such as potassium stearate and potassium behenate; alkyl ether carboxylic acid salts such as sodium POE lauryl ether carboxylate; N-acyl-L-glutamic acid salts such as N-stearoyl-L-glutamic acid monosodium salt; higher alkyl sulfuric acid ester salts such as sodium lauryl sulfate and potassium lauryl sulfate; alkyl ether sulfuric acid ester salts such as POE triethanolamine lauryl sulfate and POE sodium lauryl sulfate; N-acyl sarcosinic acid salts such as sodium lauroyl sarcosinate; higher fatty acid amide sulfonates such as N-myristoyl-N-methyltaurine sodium; alkyl phosphoric acid salts such as sodium stearyl phosphate; alkyl ether phosphoric acid salts such as such
- cationic surfactants include, but not limited to, alkyltrimethylammonium salts such as stearyltrimethylammonium chloride and lauryltrimethylammonium chloride, dialkyldimethylammonium salts such as distearyldimethylammonium chloride, poly(N,N-dimethyl-3,5-methylenepiperidinium) chloride, alkylpyridinium salts such as cetylpyridinium chloride, alkyl quaternary ammonium salts, alkyldimethylbenzylammonium salts, alkylisoquinolinium salts, dialkyl morphonium salts, POE alkylamines, alkylamine salts, polyamine fatty acid derivatives, amyl alcohol fatty acid derivatives, benzalkonium chloride, and benzethonium chloride.
- alkyltrimethylammonium salts such as stearyltrimethylammonium chloride and lauryltrimethylammonium chloride
- amphoteric surfactants include, but not limited to: imidazoline type amphoteric surfactants such as 2-undecyl-N,N,N-(hydroxyethyl carboxymethyl)-2-imidazoline sodium salt and 2-cocoyl-2-imidazolinium hydroxide-1-carboxyethyloxy 2 sodium salt; and betaine type surfactants such as 2-heptadecyl-N-carboxymethyl-N-hydroxyethyl imidazolinium betaine, lauryldimethylaminoacetic acid betaine, alkyl betaine, amide betaine, and sulfobetaine.
- imidazoline type amphoteric surfactants such as 2-undecyl-N,N,N-(hydroxyethyl carboxymethyl)-2-imidazoline sodium salt and 2-cocoyl-2-imidazolinium hydroxide-1-carboxyethyloxy 2 sodium salt
- betaine type surfactants such as 2-hepta
- the emulsifier is not particularly limited so long as it is commonly used in cosmetics, and, for example, a polymer that functions as a polymer emulsifier can be used.
- a polymer that functions as a polymer emulsifier can be used.
- examples of such polymers include acrylic acid/alkyl methacrylate copolymers, and commercially available products known as Carbopol 1342, Pemulen TR-1, and Pemulen TR-2 can be used.
- the cosmetic according to the present invention comprises water as the aqueous component.
- This water is not limited in particular.
- purified water, ion-exchanged water, or tap water can be used.
- Aqueous components commonly used in cosmetics other than water, such as water-soluble alcohol and the like, can be blended to the aqueous phase of the cosmetic according to the present invention within the range of not adversely affecting the effect of the present invention.
- water-soluble alcohols include, but not limited to, lower alcohols, polyhydric alcohols, polyhydric alcohol polymers, dihydric alcohol alkyl ethers, dihydric alcohol ether esters, glycerin monoalkyl ethers, and sugar alcohols.
- lower alcohols include, but not limited to, ethanol, propanol, isopropanol, isobutyl alcohol, and t-butyl alcohol.
- polyhydric alcohols include, but not limited to: dihydric alcohols (e.g., dipropylene glycol, 1,3-butylene glycol, ethylene glycol, trimethylene glycol, 1,2-butylene glycol, tetramethylene glycol, 2,3-butylene glycol, pentamethylene glycol, 2-butene-1,4-diol, hexylene glycol, and octylene glycol); trihydric alcohols (e.g., glycerin and trimethylolpropane); tetrahydric alcohols (e.g., diglycerin and pentaerythritol such as 1,2,6-hexanetriol); pentahydric alcohols (e.g., xylitol and triglycerin); hexahydric alcohols (e.g., sorbitol and mannitol); polyhydric alcohol polymers (e.g., diethylene glycol, dipropylene glycol
- components commonly used in cosmetics can be blended to the cosmetic of the present invention within the range of not adversely affecting the effect of the present invention.
- examples of such components include, but not limited to, moisturizers, ultraviolet absorbents, medicinal components, transdermal absorption promoters, sequestrants, powder components, vitamins, pH adjusters, antioxidants, antiseptic agents, antibacterial agents, neutralizers, perfumes and pigments.
- the cosmetic of the present invention can be in a product form such as lotions, emulsions, beauty serums, creams, and makeup bases. Lotions, emulsions, and beauty serums are particularly preferred.
- the cosmetic according to the present invention can be prepared by an ordinary method.
- it may be prepared by: mixing and dissolving oil phase components; and adding the solution while stirring to aqueous phase components to emulsify.
- Acrylic acid (2511 mg) and V-501 (0.17 mg) were dissolved in ion-exchanged water (9 mL), a methanol solution (1 ml) in which CPD (0.17 mg) had been dissolved was added, and a polymerization reaction was carried out under an argon atmosphere at 60° C. for 24 hours. After the polymerization reaction, sodium hydroxide aqueous solution was added for adjusting the pH to 6.0 to 7.0, and the mixture was dialyzed against purified water for 4 days. After freeze-drying, precisely synthesized sodium polyacrylate-1 (1.82 g, yield: 72%) was collected. As a result of GPC analysis, the weight-average molecular weight was 7,300,000, and the molecular weight distribution was 1.2.
- Acrylic acid (120 g) and V-501 (0.12 g) were dissolved in ion-exchanged water (760 g), a methanol solution (95 g) in which CPD (0.12 g) had been dissolved was added, and a polymerization reaction was carried out under an argon atmosphere at 60° C. for 96 hours. After the polymerization reaction, sodium hydroxide aqueous solution was added for adjusting the pH to 6.0 to 7.0, and the mixture was purified by re-precipitation using water/acetone. After drying under reduced pressure, precisely synthesized sodium polyacrylate-3 (75.6 g, yield: 63%) was collected. As a result of GPC analysis, the weight-average molecular weight was 695,000, and the molecular weight distribution was 1.3.
- the content of molecular species having a molecular weight of 10,000,000 or more and the content of the compound having a molecular weight equal three times or greater than the weight-average molecular weight are both more than 10% by mass (already analyzed in Patent Literature 2).
- Oil-in-water emulsion cosmetics having the formulations shown in Tables 1 and 2 were prepared by the following production methods, and the physical properties were evaluated by the following methods. Furthermore, the actual application tests were carried out by professional panelists for the following items (1) to (6). The results are shown in Tables 1 and 2.
- composition was stored at 25° C. and then rotated (12 rpm) for one minute to measure the viscosity value (mPa s) with a B-type rotational viscometer (Vismetron viscometer, manufactured by Shibaura Systems Co., Ltd.).
- the pH at 25° C. was measured with a pH meter (HORIBA pH METER F-52, manufactured by HORIBA Ltd.).
- the first normal stress difference of each composition was calculated, and then the calculated first normal stress difference was divided by the shear velocity (see Patent Literature 1). The value obtained thereby was calculated as the gradient of the first normal stress difference.
- the measurement value of the first normal stress difference (Pa) with respect to the shear velocity (s ⁇ 1 ) at the shear velocity of 100 s ⁇ 1 or more was plotted, and the slope by linear approximation was calculated as the slope of the first normal stress difference (Pa-s).
- the change in elastic modulus of the composition corresponding to the change in strain upon applying a frequency of 1 Hz was measured, and a loss elastic modulus G′′ and a storage elastic modulus G′ under specific strain conditions were calculated.
- test compositions Ten professional panelists applied the test compositions to their faces, and evaluated whether the test compositions were effective or not in: (1) rich feeling, (2) full-bodied feeling, (3) freshness, (4) non-stringiness, (5) good spreadability, and (6) non-stickiness. The answers were totalized according to the following criteria, and the results are shown in the tables.
- a and B were determined as being acceptable, and C and D were determined as being unacceptable.
- the beauty serum containing (b): (acrylates/alkyl (C10-30) acrylate) crosspolymer and a carboxyvinyl polymer, which are not precisely synthesized polymers, as thickeners were excellent in freshness, non-stringiness, spreadability, and non-stickiness, but not sufficient in rich feeling and full-bodied feeling (Comparative Example 1).
- the beauty serum in which the precisely synthesized sodium polyacrylate (Synthesis Example 1) was added to the formulation of Comparative Example 1 the viscoelastic ratio (tan ⁇ ) and the gradient of the first normal stress difference significantly increased, and thus extremely good rich feeling and full-bodied feeling could be achieved in addition to the effects such as freshness and the like (Example 1).
- FIG. 1 shows the viscoelastic ratio and the gradient of the first normal stress difference when the component (a) and the component (b) are used alone or in combination.
- the beauty serums plotted in the first quadrant of FIG. 1 (the viscoelastic ratio is greater than 1.0, and the gradient of the first normal stress difference is greater than 0.10) have sufficient viscoelastic ratio and gradient of the first normal stress difference, and can be determined as being capable of exhibiting rich feeling and full-bodied feeling.
- the component (a) and the component (b) are plotted in the second quadrant or the third quadrant when used alone.
- the values on both the x-axis and the Y-axis becomes higher than the sum of the values obtained when the component (a) and the component (b) are used alone, and are plotted in the first quadrant.
- the effect achieved by adding the precisely synthesized sodium polyacrylate is due to the point that the polymer is molecularly controlled; that is, the weight-average molecular weight being 500,000 to 8,000,000, the content of compounds having a molecular weight of 10,000,000 or more being 10% by mass or less, and the polymer being linear.
- Oil-in-water emulsion cosmetics having the formulations shown in Table 3 were prepared by an ordinary method, and the physical properties and the feeling upon use were evaluated in the same manner as in Test Example 1. The results are shown in Table 3.
- sodium polyacrylate was produced by a polymerization method different from the RAFT polymerization method used in the present application, and the thread length was measured.
- the polymerization method that uses 2-mercaptoethanol as a chain transfer agent as disclosed in Example 1 of Japanese Patent No. 5076428 B was employed.
- the monomer mixture in which the dissolved oxygen is sufficiently replaced with argon was added to an 85.7 ⁇ p polystyrene dish, lidded, and thermally polymerized in a thermostat (Model ADP300 manufactured by Yamato Scientific Co., Ltd.) at 60° C., and obtained a gel-like substance as in Example 1 of Japanese Patent No. 5076428 B (in Example 1 of Japanese Patent No. 5076428 B, the temperature was raised to about 60° C. by UV lamp irradiation, but the same conditions were reproduced with a thermostat).
- the gel-like substance was stirred and dissolved in pure water, and then dialyzed with a dialysis tube (Fisherbrand regenerated cellulose having a pore size of 10 ⁇ ). After dialysis, white polymer powder was collected by freeze-drying (FDU2100, Tokyo Rikakikai Co., Ltd.).
- Patent Literature 2 The apparatus and conditions described in Patent Literature 2 were used for evaluations. Specifically, a 1% by mass aqueous solution of the obtained sodium polyacrylate was prepared and stored in a container at room temperature. The container was set on a texture analyzer (TA.XT plus, manufactured by Stable Micro Systems), a round disk having a diameter of about 1 cm was uniformly and lightly brought into contact with the surface of the aqueous solution, and then the container was lowered at a velocity of 5 mm/sec to observe how the solution forms a thread. The distance that the container was lowered until the thread of the solution was cut was measured as a “thread length.” This thread length is a value that serves an index of stringiness of the polymer compound, and a greater value indicates a greater stringiness. When the thread length was 10 mm or less, the stringiness was determined as being low.
- TA.XT plus manufactured by Stable Micro Systems
- the precisely synthesized sodium polyacrylate-1 synthesized by the method of Synthesis Example 1 of the present application did not show any stringiness by visual observation, and the thread length was 6 mm.
- the viscosity of the 0.2% by mass aqueous solution of the sodium polyacrylate was 64.4 mPa-s. It is generally known that the stringiness of a polymer tends to correlate with viscosity and viscoelasticity.
- Formulation Example 1 Cosmetic Lotion Formulation Blending amount Component (% by mass) Ethyl alcohol 5 Glycerin 1 1,3-Butylene glycol 5 Polyoxyethylene polyoxypropylene 0.2 decyltetradecyl ether Sodium hexametaphosphate 0.03 Trimethylglycine 1 Sodium polyaspartate 0.1 Ascorbic acid dl- ⁇ -tocopherol 0.1 phosphoric acid diester potassium salt Thiotaurine 0.1 Green tea extract 0.1 Mentha Piperita (Peppermint) leaf 0.1 extract Iris Florentina Root extract 1 EDTA 3Na 0.1 Carboxyvinyl polymer 0.05 Precisely synthesized sodium 0.01 poly acrylate (Synthesis Example 1) Potassium hydroxide 0.02 Phenoxyethanol Suitable amount Perfume Suitable amount Purified water Balance Total: 100.0
- Formulation Example 2 Cosmetic Lotion Blending Formulation amount Component (% by mass) Dipropylene glycol 5 Glycerin 6 Butylene glycol 7 Polyethylene glycol 5 Methyl gluceth-10 2 Triethylhexanoin 0.3 PEG-60 hydrogenated castor oil 0.5 Polyglyceryl-2 diisostearate 0.4 Carboxyvinyl polymer 0.05 Precisely synthesized sodium 0.05 polyacrylate (Synthesis Example 1) Potassium hydroxide 0.02 Tranexamic acid 1 Sodium alginate 0.1 Citric acid Suitable amount Phenoxyethanol Suitable amount Sodium metaphosphate Suitable amount Perfume Suitable amount Purified water Balance Total: 100.0
- Formulation Example 3 Cosmetic Lotion Formulation Blending amount Component (% by mass) Glycerin 2 1,3-Butylene glycol 4 Erythritol 1 Polyoxyethylene methyl glucoside 1 Polyoxyethylene hydrogenated castor oil 0.5 Dimethyl acrylamide Crosslinked sodium N,N-dimethylacrylamide-2- acrylamido-2-methylpropanesulfonic acid copolymer Precisely synthesized sodium polyacrylate 0.03 (Synthesis Example 2) N-coconut oil fatty acid acyl-L-arginine-ethyl 0.1 DL-pyrrolidonecarboxylic acid Citric acid 0.02 Sodium citrate 0.08 Phenoxyethanol Suitable amount Purified water Balance Total: 100.0
- Formulation Example 4 Cosmetic Lotion Formulation Blending amount Component (% by mass) Glycerin 10 Ethanol 5 Dipropylene glycol 6 PEG/PPG-14/7 dimethyl ether 1 PPG-1 3 decyltetradeceth-24 0.5 (Acryloyldimethylltaurate/VP) copolymer 0.05 Precisely synthesized sodium polyacrylate 0.03 (Synthesis Example 3) Lactic acid 1 Tranexamic acid 2 Xanthan gum 0.1 Citric acid Suitable amount Sodium citrate Suitable amount Phenoxyethanol Suitable amount Disodium edetate Suitable amount Perfume Suitable amount Purified water Balance Total: 100.0
- Formulation Example 5 Cosmetic Lotion Formulation Blending amount Component (% by mass) Mineral oil 0.5 Isostearyl alcohol 0.5 Glycerin 4 Dipropylene glycol 5 Butylene glycol 5 Polyethylene glycol 4 Isostearic acid 1 PEG/PPG-14/7 dimethyl ether 5 Sorbitan sesquiisostearate 0.3 PEG-30 soy sterol 1 (Acryloyldimethyltaurate/beheneth-25 0.05 methacrylate) copolymer Precisely synthesized sodium polyacrylate 0.05 (Synthesis Example 3) Tranexamic acid 1 Dipotassium glycyrrhizinate 0.05 Citric acid Suitable amount Sodium metaphosphate Suitable amount Phenoxyethanol Suitable amount Perfume Suitable amount Purified water Balance Total: 100.0
- Formulation Example 6 Whitening Emulsion Formulation Blending amount Component (% by mass) Hydrogenated polydecene 1 Dimethicone 1 Cyclomethicone 2 Behenyl alcohol 0.2 Batyl alcohol 0.1 Glycerin 1 Butylene glycol 8 Cetyl ethylhexanoate 2 Polysorbate 60 0.1 PEG-60 hydrogenated castor oil 0.1 Ascorbyl glucoside 2 Xanthan gum 0.05 Sodium polyacrylate/acryloyldimethyl 2.5 taurate copolymer dispersion (actual content) Acrylic acid/alkyl methacrylate 0.1 copolymer Precisely synthesized sodium 0.5 polyacrylate (Synthesis Example 1) Disodium edetate Suitable amount Potassium hydroxide Suitable amount Citric acid Suitable amount Sodium metaphosphate Suitable amount Phenoxyethanol Suitable amount Iron oxide Suitable amount Purified water Balance Total: 100.0
- Formulation Example 7 Emulsion Formulation Blending amount Component (% by mass) Carboxydecyl trisiloxane 1 Dimethicone 1.5 Cyclomethicone 2.5 Diphenylsiloxy phenyl trimethicone 1 Behenyl alcohol 1 Batyl alcohol ] Glycerin 2 Dipropylene glycol 7 Glyceryl stearate (SE) 1 PEG-5 glyceryl stearate 0.5 Tranexamic acid 2 Carbomer 0.1 Precisely synthesized sodium polyacrylate 0.3 (Synthesis Example 2) Potassium hydroxide Suitable amount Sodium metaphosphate Suitable amount Iron oxide Suitable amount Phenoxyethanol Suitable amount Di sodium edetate Suitable amount Perfume Suitable amount Purified water Balance Total: 100.0
- Formulation Example 8 Emulsion Formulation Blending amount Component (% by mass) Hydrogenated polydecene 7 Vaseline 1 Dimethicone 1 Ethanol 2 Behenyl alcohol 1 2 Glycerin 8 Butylene glycol 4 Stearic acid 0.5 Behenic acid 0.5 Ceteth-25 0.3 Sodium stearoyl glutamate 0.3 Crosslinked sodium N,N-dimethylacrylamide-2- 0.5 acrylamido-2-methylpropanesulfonic acid copolymer Precisely synthesized sodium polyacrylate 0.8 (Synthesis Example 2) 4-Methoxysalicylic acid potassium salt 1 Tranexamic acid 2 Tocopherol acetate 1 Potassium hydroxide Suitable amount Phenoxyethanol Suitable amount Di sodium edetate Suitable amount Perfume Suitable amount Purified water Balance Total: 100.0
- Formulation Example 9 Emulsion Formulation Blending amount Component (% by mass) Vaseline 5 Behenyl alcohol 0.5 Batyl alcohol 0.5 Glycerin 7 1,3-Butylene glycol 7 1,2-Pentanediol 1 Xylit 3 Polyethylene glycol 20000 2 Hydrogenated oil 9 Jojoba oil 2 Squalane 5 Isostearic acid 0.5 Pentaerythrityl tetra-2 -ethylhexanoate 2 Polyoxyethylene hydrogenated castor oil 0.5 Betaine lauryldimethylaminoacetate 0.4 Sodium pyrosulfite 0.01 Sodium hexametaphosphate 0.05 Dipotassium glycyrrhizinate 0.05 Trimethvlglycine 3 Arbutin 3 Yeast extract 0.1 Tocopherol acetate 0.1 Thiotaurine 0.1 Sophora Angustifolia Root extract 0.1 Pyrus Cydonia Seed extract 0.1 Carboxyvinyl polymer 0.2 Preci
- Formulation Example 10 Emulsion Formulation Blending amount Component (% by mass) Dimethyl polysiloxane 3 Decamethylcyclopentasiloxane 4 Ethanol 5 Glycerin 6 1,3-Butylene glycol 5 Polyoxyethylene methyl glucoside 3 Sunflower oil 1 Squalane 2 Potassium hydroxide 0.1 Sodium hexametaphosphate 0.05 Hydroxypropyl- ⁇ -cyclodextrin 0.1 Dipotassium glycyrrhizinate 0.05 Eriobotrya Japonica Leaf extract 0.1 L-sodium glutamate 0.05 Fennel extract 0.1 Yeast extract 0.1 Lavender oil 0.1 Rehmannia Root extract 0.1 Dimorpholinopyridazinone 0.1 Xanthan gum 0.1 Carboxyvinyl polymer 0.1 Acrylic acid/alkyl methacrylate copolymer 0.1 Precisely synthesized sodium poly acrylate 0.5 (Synthesis Example 1) Red iron oxide Suitable amount Yellow
- Formulation Example 11 Emulsion Formulation Blending amount Component (% by mass) Dimethicone 2 Ethanol 3 Behenyl alcohol 1 Glycerin 3 Dipropylene glycol 5 Butylene glycol 3 Triethylhexanoin 1 Sodium methyl stearoyl taurate 0.1 Citric acid 0.18 Sodium citrate 0.02 Tranexamic acid 2 Xanthan gum 0.05 (Acryl oyldimethyl taurate/beheneth-25 methacrylate) 0.5 copolymer Precisely synthesized sodium polyacrylate 0.5 (Synthesis Example 1) Phenoxyethanol Suitable amount Disodium edetate Suitable amount Perfume Suitable amount Purified water Balance Total: 100.0
- Formulation Example 12 Emulsion Formulation Blending amount Component (% by mass) Dimethyl poly siloxane 3 Methylphenyl polysiloxane 3 Ethanol 5 Glycerin 4 Di propylene glycol 5 1,3-Butylene glycol 5 Di-2-ethylhexyl succinate 3.5 Potassium hydroxide 0.1 Sodium hexametaphosphate 0.1 Thiotaurine 0.1 Edetate trisodium 0.1 4-t-butyl-4′-methoxy dibenzoylemethane 3 2- Ethylhexyl p-methoxycinnamate 3 Iron oxide 0.01 Acrylic acid/alkyl methacrylate copolymer 0.1 (Acryloyldimethylltaurate/VP) copolymer 0.05 Precisely synthesized sodium poly acrylate 0.5 (Synthesis Example 2) Paraben Suitable amount Perfume Suitable amount Purified water Balance Total: 100.0
- Formulation Example 13 Gel Formulation Blending amount Component (% by mass) Dimethyl polysiloxane 5 Glycerin 2 1,3-Butylene glycol 5 Polyethylene glycol 1500 3 Polyethylene glycol 20000 3 Cetyl octanoate 3 Citric acid 0.01 Sodium citrate 0.1 Sodium hexametaphosphate 0.1 Dipotassium glycyrrhizinate 0.1 Ascorbyl glucoside 2 Tocopherol acetate 0.1 Scutellaria Baicalensis extract 0.1 Saxifraga Sarmentosa extract 0.1 Edetate trisodium 0.1 Xanthan gum 0.3 Acrylic acid/alkyl methacrylate copolymer 0.05 Agar powder 1.5 Precisely synthesized sodium polyacrylate 0.2 (Synthesis Example 1) Phenoxyethanol Suitable amount Dibutyl hydroxytoluene Suitable amount Purified water Balance Total: 100.0
- a translucent emulsion composition was produced by an ordinary method and cooled to 30° C. or lower to be gelated. When the gel was sufficiently solidified, the gel was crushed by a disper to give a microgel (having an average particle size of 70 ⁇ m). Then the microgel was degassed to give a gel-like product.
- Formulation Example 14 Beauty Serum Formulation Biending amount Component (% by mass) Ethanol 10 PPG-13 decyltetradeceth-24 0.1 Salicylic acid 0.5 Tranexamic acid 1 Xanthan gum 0.2 Gellan gum 0.5 Sodium chloride 0.9 Potassium hydroxide Suitable amount Sodium pyrosulfite Suitable amount Disodium edetate Suitable amount Purified water Balance Total: 100.0
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Transportation (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Automation & Control Theory (AREA)
- Combustion & Propulsion (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Mathematical Physics (AREA)
- Electric Propulsion And Braking For Vehicles (AREA)
- Hybrid Electric Vehicles (AREA)
- Cosmetics (AREA)
Abstract
Description
- This application is a continuation/divisional under § 1.53(b) of U.S. patent application Ser. No. 16/954,504, filed on Jun. 16, 2020, which is based upon and claims the benefit of the priority of PCT/JP2018/048064 filed Dec. 27, 2018, the entire contents of which are incorporated herein by reference which in turn claims the benefit of the priority of Japanese Patent Application No. 2017-254460, filed on Dec. 28, 2017, the entire disclosures of which are incorporated herein by reference.
-
FIG. 1 - The present invention relates to a cosmetic, and more specifically to a cosmetic blended with a precisely synthesized polymer.
- Freshness, good spreadability, and non-stickiness are properties desired to many cosmetics, but it is not easy to exhibit rich feeling and full-bodied feeling without impairing these properties.
- It is generally known that rich feeling of cosmetics correlates with the viscoelastic ratio thereof, and full-bodied feeling can be evaluated with the gradient of the first normal stress difference (Patent Literature 1).
- The viscoelastic ratio and the gradient of the first normal stress difference of cosmetics greatly depend on blending of thickeners. Examples of thickeners commonly used in cosmetics include anionic polymers and polysaccharides. When anionic polymers absorb water, they gelate and exhibit a thickening effect; however, it is difficult to exhibit rich feeling and full-bodied feeling when blended in large amounts and, stringiness (thread-forming property), which is undesirable for cosmetics, tends occur. Moreover, polysaccharides have a problem of causing stickiness when blended in large amounts since they do not penetrate the skin and remain on the skin.
- Under such circumstances, a component that does not have stringiness and is capable of imparting rich feeling and full-bodied feeling without impairing freshness, good spreadability, and non-stickiness of a cosmetic was desired.
-
- Patent Literature 1: Japanese Unexamined Patent Publication No. 2013-137266 A.
- Patent Literature 2: International Publication No. WO2015/052804 A
- Patent Literature 3: Japanese Patent No. 5076428 B.
- The present invention was made in view of the above-described problems in conventional art, and an object of the present invention is to provide a cosmetic that is excellent in rich feeling and full-bodied feeling, does not have stringiness, and is also excellent in freshness, spreadability, and non-stickiness.
- The present inventors have been working on the development of thickeners that are suitable for cosmetics, and have reported that “polyacrylic acid or a salt thereof or poly(2-acrylamido-2-methylpropanesulfonic acid) or a salt thereof that has the weight-average molecular weight of 500,000 to 8,000,000, has the content of molecular species having the molecular weight of 10,000,000 or more of 10% by mass or less; and is linear” can be used as a thickener capable of providing a thickening effect to cosmetics without imparting stringiness (Patent Literature 2). It is described that this effect can be obtained because the stringiness is significantly reduced with the “polyacrylic acid or a salt thereof or poly(2-acrylamido-2-methylpropane-sulfonic acid) or a salt thereof” than the compound of a conventional one (Patent Literature 2).
- The present inventors have diligently studied the above-described problems. As a result, they have found that when the “polyacrylic acid or a salt thereof or poly(2-acrylamido-2-methylpropanesulfonic acid) or a salt thereof” is added to an aqueous phase in which a commonly used thickener is dissolved, the viscoelastic ratio and the gradient of the first linear stress difference increase synergistically, and significant rich feeling and full-bodied feeling can be exhibited. Moreover, the present inventors have found that a cosmetic prepared by using said thickener in combination has excellent rich feeling and full-bodied feeling, does not have stringiness, and also has excellent freshness, spreadability, and non-stickiness, and thus completed the present invention.
- That is, the present invention encompasses the following.
- [1] A cosmetic comprising components (a) and (b):
- (a) polyacrylic acid or a salt thereof or poly(2-acrylamido-2-methylpropanesulfonic acid) or a salt thereof that has a weight-average molecular weight of 500,000 to 8,000,000, is linear, and has a thread length of 10 mm or less at room temperature when formed into a 1% by mass solution, wherein the thread length is a distance determined by: putting a round disk having a diameter of about 1 cm uniformly and lightly into contact with a surface of the solution; lowering a container that contains the solution at a velocity of 5 mm/sec, and measuring the distance that the container descended until a thread of the solution is cut, and
- (b) a crosslinked water-swellable polymer having a crosslinking density of 0.01 to 1 mol %, or a microgel obtained by pulverizing a gel consisting of a hydrophilic compound having gelation ability.
- [2] The cosmetic according to [1], wherein the crosslinked water-swellable polymer of the component (b) is one or more selected from the group consisting of a carboxyvinyl polymer, acrylamidealkylsulfonic acid/beheneth-25 crosslinked copolymer, acrylamidealkylsulfonic acid/vinylpyrrolidone crosslinked copolymer and acrylamidealkylsulfonic acid/alkylacrylamide crosslinked copolymer.
- [3] The cosmetic according to [1] or [2], wherein the microgel of the component (b) is a hydrophilic polysaccharide.
- [4] The cosmetic according to any one of [1] to [3], wherein the content of the compound having the molecular weight of 10,000,000 or more in the component (a) is 10% by mass or less.
- The present invention provides a cosmetic that is excellent in rich feeling and full-bodied feeling, does not have stringiness, and also excellent in freshness, spreadability, and non-stickiness.
-
FIG. 1 is a graph showing the results of analyzing the viscoelastic ratio, which is an index of rich feeling, and the gradient of the first normal stress difference, which is an index of full-bodied feeling, of the thickeners used in the Examples of the present application. - Preferred embodiments of the present invention are described in the following.
- Herein, the “linear polymer having a weight-average molecular weight of 500,000 to 8,000,000 and a thread length of 10 mm or less at room temperature when formed into a 1% by mass solution” may be referred to as a “precisely synthesized polymer”. The “thread length” is a value measured by the method described in Patent Literature 2. Namely, a value defined as “a distance determined by putting a round disk having a diameter of about 1 cm uniformly and lightly into contact with a surface of the solution, lowering a container at the velocity of 5 mm/sec, and measuring the distance that the container descended until a thread of the solution is cut”. In the “linear polymer having the weight-average molecular weight of 500,000 to 8,000,000” that satisfies the requirement of the thread length, the “content of molecular species having the molecular weight of 10,000,000 or more” is usually “10% by mass or less”, and thus the requirement of “the content of molecular species having a molecular weight of 10,000,000 or more is 10% by mass or less” may be optional.
- Polyacrylic acid and poly(2-acrylamido-2-methylpropanesulfonic acid) having the properties of the precisely synthesized polymer may be referred to as “precisely synthesized polyacrylic acid” and “precisely synthesized PAMPS,” respectively. Here, “PAMPS” is an abbreviation for poly(2-acrylamido-2-methylpropanesulfonic acid).
- Moreover, in the precisely synthesized polymer, the content of the compound having the molecular weight that is three times or more of the weight-average molecular weight may be 10% by mass or less. This is because the stringiness of the precisely synthesized polymer tends to be reduced more.
- [Component (a)]
- In the present invention, polyacrylic acid or a salt thereof or poly(2-acrylamido-2-methylpropanesulfonic acid) or a salt thereof that has a weight-average molecular weight of 500,000 to 8,000,000, has a thread length of 10 mm or less at room temperature when formed into a 1% by mass solution, and is linear can be used as the component (a). Namely, the precisely synthesized polyacrylic acid or a salt thereof or the precisely synthesized PAMPS or a salt thereof can be used as the component (a).
- Examples of the kinds of the above-described salts include alkali metal salts (for example, sodium salt, potassium salt, magnesium salt, calcium salt, etc.), organic amine salts (for example, monoethanolamine salt, diethanolamine salt, triethanolamine salt, triisopropanolamine salt, etc.), and the salts of basic nitrogen-containing compounds such as 2-amino-2-methyl-1-propanol, 2-amino-2-methyl-1,3-propanediol, 2-amino-2-hydroxymethyl-1,3-propanediol, L-arginine, L-lysine, and L-alkyl taurine, etc. Among them, monovalent alkali metal salts and organic amine salts are preferred, a sodium salt, potassium salt and triethanolamine salt are more preferred, and a sodium salt is the most preferred.
- In the present invention, the polyacrylic acid salt or PAMPS salt indicates a compound obtained by neutralizing the polyacrylic acid or PAMPS with the above-described base (namely, the above-described alkali metals, organic amines, basic nitrogen-containing compounds, etc.) or a compound obtained by polymerizing the acrylic acid or 2-acrylamide-2-methylpropanesulfonic acid (hereinafter abbreviated as AMPS) whose acid section is neutralized in advance with the above-described base.
- As the examples of the precisely synthesized polymers, those that can be synthesized by a RAFT polymerization method to be described later are preferable. Examples include homopolymers and/or salts thereof in which acrylic acid monomers such as methacrylic acid, alkyl acrylates, alkyl methacrylates, acrylic acid esters; acrylamide monomers such as acrylamide and dimethylacrylamide; vinyl monomers such as vinyl alcohol, vinylpyrrolidone, vinyl acetate, carboxyvinyl, and vinyl methyl ether; and styrene, urethane, etc. are the constituent unit monomer; and copolymers and/or salts thereof consisting of two kinds or more of the monomers selected from these monomers, acrylic acid, and AMPS. Among them, those in which the constituent unit is an acrylic acid monomer or acrylamide monomer are especially preferable. Furthermore, macro-monomers in which polyethylene glycol, silicone-based polymer compound, etc. are added to the above-described monomer, as the side chain, can also suitably be used as the constituent unit.
- Specific examples of the compound include polyacrylamide, polydimethylacrylamide, polyvinyl alcohol, polyvinylpyrrolidone, polyvinylmethyl ether, polyvinyl acetate, carboxyvinyl polymer, etc.; and (acrylic acid/alkyl acrylate) copolymer, (acrylic acid/alkyl methacrylate) copolymer, (alkyl acrylate/styrene) copolymer, polyacrylic acid ester copolymer, (dimethylacrylamide/2-acrylamido-2-methylpropanesulfonic acid) copolymer and salts thereof.
- The amount of the component (a) blended in the cosmetic according to the present invention is 0.005 to 2% by mass, preferably 0.005 to 1.5% by mass, and more preferably 0.005 to 1% by mass. When the blending amount is less than 0.005% by mass, a sufficient normal stress may not be achieved, and when the blending amount exceeds 2% by mass, the normal stress may be too high and cause a slimy texture.
- Method for Synthesizing Precisely Synthesized Polymer
- The precisely synthesized polymer of the present invention can be synthesized by a publicly known living polymerization method. Examples of living polymerization include living anionic polymerization, living cationic polymerization, living radical polymerization (precise radical polymerization, or controlled radical polymerization), etc.
- Examples of living radical polymerization include (radical) polymerization that is mediated by nitroxide, or nitroxide-mediated (radical) polymerization (NLRP), atom transfer radical polymerization (ATRP), reversible addition-fragmentation chain transfer (RAFT) polymerization, etc. Examples of atom transfer radical polymerization (ATRP) include electron transfer generated activator ATRP, or activators generated by electron transfer ATRP (AGET ATRP), electron transfer regenerated activator ATRP, or activators regenerated by electron transfer ATRP (ARGET ATRP), initiators to continuously regenerate active species ATRP, or initiators for continuous activator regeneration ATRP (ICAR ATRP), and reverse ATRP (Reverse ATRP). The RAFT polymerization method is a living radical polymerization method that uses a RAFT agent as a chain transfer agent. Examples of a derivative technology of the RAFT polymerization include living radical polymerization in which organic tellurium is the growing end, or organic tellurium-mediated living radical polymerization (TERP), antimony-mediated living radical polymerization (SBRP), and bismuth-mediated living radical polymerization (BIRP), etc. Examples of other living radical polymerizations include iodine transfer radical polymerization (IRP), cobalt-mediated radical polymerization (CMRP), etc.
- The direct polymerization of acrylic acid is preferable because of the simplicity of polymerization. However, when the polymerization is difficult because of the formation of insoluble salts such as catalysts, protected acrylic acid esters such as t-butyl acrylate, methoxymethyl acrylate, and methyl acrylate are used, and the desired polymer compound can be obtained by the succeeding deprotection.
- In the present invention, the living radical polymerization method is preferable because the precision synthesis of a high molecular weight body (namely, the synthesis of polymer compounds with narrow molecular weight distribution) is possible, and the reversible addition-fragmentation chain transfer polymerization method (RAFT polymerization method) is more preferable (Patent Literature 2).
- It is also known that secondary reactions such as branching and crosslinking easily occur in other polymerization methods, but branching and crosslinking does not occur easily in the living radical polymerization method.
- In particular, the RAFT polymerization method is a polymerization method in which growth continues while exchanging a chain transfer agent (a RAFT agent) between active polymer ends; namely, living is achieved by a so-called exchange chain mechanism. When the RAFT agent bonds to a growth end of the polymer chain, it becomes a resting state (dormant state); and when the RAFT agent is detached, a growth reaction occurs. However, because the equilibrium state of bonding is significantly biased toward the bonding side (i.e., the time when the RAFT agent is bonded is much longer than the time when the RAFT agent is detached), the growth rate of the polymer chain is very slow, and the reactivity of the end can be suppressed. Accordingly, since the rate of the growing reaction in each polymer chain becomes the same, and the degree of polymerization of the polymer is basically proportional to the reaction time, a polymer having an extremely narrow molecular weight distribution can be obtained. Moreover, since the reactivity is low, it is considered that secondary reactions such as branching and crosslinking does not occur easily.
- A dithiocarbonyl compound and a trithiocarbonyl compound can be preferably used as RAFT agents (i.e., chain transfer agents). Dithiocarbamate and trithiocarbamate are more preferred, and 4-cyanopentanoic acid dithiobenzoate and α-(methyltrithiocarbonate)-S-phenylacetic acid are most preferred. The polymerization initiator that has a similar chemical structure as that of the chain transfer agent is preferred, and an azo initiator is preferred. The polymerization solvent is not limited in particular, and those having high solubility of monomers and polymers are suitably selected. The polymerization time is preferably several hours to 100 hours.
- Method for Measuring Molecular Weight
- The molecular weight of the precisely synthesized polymer can be measured by publicly known methods, such as a light scattering method, an ultracentrifugal method, and a chromatographic method for the weight-average molecular weight; and an osmometric method and a chromatographic method for the number-average molecular weight. Among them, the chromatographic method is preferred because the weight-average molecular weight, the number-average molecular weight, and the molecular weight distribution can easily be obtained with a small amount of sample; in particular, a gel permeation chromatographic method (hereinafter abbreviated as GPC) is preferred.
- The molecular weight distribution used in this application is the value determined by dividing the weight-average molecular weight obtained by GPC analysis by the number-average molecular weight.
- Component (b)
- In the present invention, (b) a crosslinked water-swellable polymer having a crosslinking density of 0.01 to 1 mol %, or a microgel obtained by crushing a gel consisting of a hydrophilic compound having gelation ability can be used as the component (b).
- The crosslinked water-swellable polymer may be a polymer based on (meth)acrylic acid or modified (meth)acrylic acid. Examples thereof include, but not limited to: crosslinked polymers of acrylic acid represented by a carboxyvinyl polymer (a carbomer), copolymers of (meth)acrylic acid and polyalkylene polyether, hydrophobically modified poly(meth)acrylates, (meth)acrylate/C10-30 alkyl acrylate polymers, (meth)acrylates/beheneth-25 methacrylate copolymers, (meth)acrylate/(meth)acrylamide copolymers, (meth)acrylate/(meth)alkylacrylamide copolymers, (meth)acrylate/(meth)hydroxyethylacrylamide copolymers, and (meth)acrylate/polyalkyleneoxide alkyl-modified (meth)acrylates.
- Moreover, a copolymer based on polysulfonic acid, preferably acrylamidoalkylsulfonic acid and/or a salt thereof, and one or more comonomers selected from cyclic N-vinylcarboxamides and linear N-vinylcarboxamides, or a crosslinked acrylamidoalkylsulfonic acid copolymer; a crosslinked homopolymer of acrylamidoalkylsulfonic acid and/or a salt thereof; a copolymer of acrylamidoalkylsulfonic acid and/or a salt thereof, and a comonomer selected from (meth)acrylamide, (meth)alkylacrylamide, (meth)hydroxyethylacrylamide, polyalkyleneoxide alkyl-modified (meth)acrylate, hydroxyethyl (meth)acrylate, and cation-modified (meth)acrylates; and the like can also be used preferred.
- Among them, a carboxyvinyl polymer, an acrylamidoalkylsulfonic acid/beheneth-25 crosslinked copolymer, an acrylamidoalkylsulfonic acid/vinylpyrrolidone crosslinked copolymer, and an acrylamidoalkylsulfonic acid/alkylacrylamide crosslinked copolymer are particularly preferable.
- The crosslinking density of the crosslinked water-swellable polymer is 0.01 to 1 mol %, preferably 0.02 to 0.8 mol %, and most preferably 0.05 to 0.5 mol %. In the present invention, a polymer capable of infinitely swelling with water is not suitable.
- Examples of the microgel include a microgel obtained by dissolving a hydrophilic compound having gelation ability in water or an aqueous component, leaving the solution to cool to form a gel, and crushing the formed gel.
- The hydrophilic compound having gelation ability is not particularly limited, so long as it is a water-soluble compound having gelation ability and is used in the cosmetic and pharmaceutical fields. Specific examples include, but not limited to, hydrophilic proteins having gelation ability such as gelatin and collagen, and hydrophilic polysaccharides such as agar, curdlan, scleroglucan, schizophyllan, gellan gum, alginic acid, carrageenan, mannan, pectin, and hyaluronic acid. In particular, gelatin, agar, curdlan, gellan gum, alginic acid, and carrageenan can be used preferably because they are not easily affected by salts and ions, and are capable of forming a stable gel. One of or two or more of the hydrophilic compounds having gelation ability can be used.
- The microgel according to the present invention can be produced by the method disclosed in Japanese Patent No. 4979095 B, for example. Specifically, after the hydrophilic compound having gelation ability is dissolved in water or an aqueous component, it is left to cool and solidified to form a gel. The compound can be dissolved in water or an aqueous component by mixing, heating, or the like. Gelation (solidification) may be carried out by stopping the heating after dissolution and leaving the solution to stand (to stand still) until the temperature is lower than the gelation temperature (solidification temperature).
- Then, the formed gel is processed with a homogenizer, disper, mechanical stirrer, or the like to crush the formed gel and obtain the desired microgel. In the present invention, the average particle size of the microgel is preferably 0.1 to 1,000 μm, more preferably about 1 to 300 μm, and even more preferably about 10 to 200 μm.
- The amount of the crosslinked water-swellable polymer having a crosslinking density of 0.01 to 1 mol % blended in the cosmetic of the present invention is 0.01 to 2% by mass, preferably 0.02 to 1.5% by mass, and more preferably 0.05 to 1% by mass. When the blending amount is less than 0.01% by mass, a sufficient thickening effect may not be achieved. When the blending amount exceeds 5% by mass, stickiness may occur.
- The amount of the microgel obtained by crushing a gel, which is formed of a hydrophilic compound having gelation ability, blended in the cosmetic of the present invention is 0.1 to 5% by mass, preferably 0.15 to 4% by mass, and more preferably 0.2 to 3% by mass. When the amount is less than 0.1% by mass, a sufficient gelation ability may not be achieved. When the blending amount exceeds 5% by mass, a rough texture may occur.
- Oil Component
- The oil component that forms the oil phase of the cosmetic according to the present invention can be selected from oil components conventionally used in cosmetics and the like, and is not particularly limited. For example, the oil component may be one or two or more selected from hydrocarbon oils, higher fatty acids, higher alcohols, synthetic ester oils, silicone oils, liquid fats and oils, solid fats and oils, waxes, oil-soluble drugs, and the like.
- Examples of hydrocarbon oils include, but not limited to, isododecane, isohexadecane, isoparaffin, liquid paraffin, ozocerite, squalane, pristane, paraffin, ceresin, squalene, vaseline, and microcrystalline wax.
- Examples of higher fatty acids include, but not limited to, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, undecylenic acid, tallic acid, isostearic acid, linoleic acid, linolenic acid, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA).
- Examples of higher alcohols include, but not limited to: linear alcohols (such as lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, and cetostearyl alcohol); and branched-chain alcohols (such as monostearylglycerin ether (batyl alcohol)-2-decyltetradecinol, lanolin alcohol, cholesterol, phytosterol, hexyldodecanol, isostearyl alcohol, and octyldodecanol).
- Examples of synthetic ester oils include, but not limited to, octyl octanoate, nonyl nonanoate, cetyl octanoate, isopropyl myristate, octyl dodecyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, myristyl myristate, decyl oleate, hexyl decyl dimethyloctanoate, cetyl lactate, myristyl lactate, lanolin acetate, isocetyl stearate, isocetyl isostearate, cholesteryl 12-hydroxystearate, ethylene glycol di-2-ethylhexanoate, dipentaerythritol fatty acid ester, N-alkylene glycol monoisostearate, neopentyl glycol dicaprate, tripropylene glycol pivalate, diisostearyl malate, glyceryl di-2-heptylundecanoate, glyceryl diisostearate, trimethylolpropane tri-2-ethyl hexanoate, trimethylolpropane triisostearate, pentaerythritol tetra-2-ethylhexanoate, glycerin tri-2-ethylhexanoate, glyceryl trioctanoate, glycerin triisopalmitate, trimethylolpropane triisostearate, cetyl 2-ethyl hexanoate-2-ethylhexyl palmitate, glycerin trimyristate, tri-2-heptyl undecanoic acid glyceride, castor oil fatty acid methyl ester, oleyl oleate, aceto glyceride, 2-heptylundecyl palmitate, diisobutyl adipate, 2-octyldodecyl N-lauroyl-L-glutamate, di-2-heptylundecyl adipate, ethyl laurate, di-2-ethylhexyl sebacate, 2-hexyldecyl myristate, 2-hexyldecyl palmitate, 2-hexyldecyl adipate, diisopropyl sebacate, 2-ethylhexyl succinate, and triethyl citrate.
- Examples of silicone oils include, but not limited to, chain polysiloxanes (e.g., dimethylpolysiloxane, methylphenyl polysiloxane, diphenyl polysiloxane, etc.), ring polysiloxanes (e.g., octamethylcyclotetrasiloxane, decamethyl cyclopenta siloxane, dodecamethyl cyclohexa siloxane, etc.), silicone resins forming a three-dimensional network structure, silicone rubbers, various modified polysiloxanes (amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, fluorine-modified polysiloxane, etc.), and acryl silicones.
- Examples of liquid fats include, but not limited to, avocado oil, camellia oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, par chic oil, wheat germ oil, southern piece oil, castor oil, linseed oil, safflower oil, cotton seed oil, perilla oil, soybean oil, groundnut oil, brown real oil, torreya oil, rice bran oil, Chinese tung oil, Japanese tung oil, jojoba oil, germ oil, and triglycerol.
- Examples of solid fats include, but not limited to, cacao butter, coconut oil, horse fat, hydrogenated coconut oil, palm oil, beef tallow, sheep tallow, hydrogenated beef tallow, palm kernel oil, lard, beef bones fat, Japan wax kernel oil, hardened oil, hoof oil, Japan wax, and hydrogenated caster oil.
- Examples of waxes include, but not limited to, beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, insect wax, spermaceti, montan wax, bran wax, lanolin, kapok wax, lanolin acetate, liquid lanolin, sugarcane wax, lanolin fatty acid isopropyl ester, hexyl laurate, reduced lanolin, jojoba wax, hardened lanolin, shellac wax, POE lanolin alcohol ether, POE lanolin alcohol acetate, POE cholesterol ether, lanolin fatty acid polyethylene glycol, and POE hydrogenated lanolin alcohol ether.
- In addition to the oil components listed above, the oil phase of the oil-in-water emulsion cosmetic according to the present invention may contain oily components commonly used in cosmetics within the range of not adversely affecting the effect of the present invention.
- Surfactant
- In the present invention, various surfactants and/or emulsifiers can be used alone or in combination as an emulsifier.
- A surfactant can be suitably selected from nonionic surfactants, cationic surfactants, anionic surfactants, and amphoteric surfactants, and it is preferable that the overall HLB becomes 7 or more. Here, the HLB is an index indicating a balance between hydrophilicity and lypophilicity (a hydrophilic-lypophilic balance). In the present invention, it is a value calculated by the following equation of Oda and Teramura, et al.
-
HLB=(Σinorganic value/Σorganic value)×10 - The “overall HLB being 7 or more” means that, for example, when x % by mass of a surfactant having an HLB of “a” and (100−x) % by mass of a surfactant having an HLB of “b” are used in combination, a value of the overall HLB=a·x/100+b·(100−x)/100 is 7 or more.
- In the following description, POE means polyoxyethylene, and POP means polyoxypropylene, respectively.
- Examples of nonionic surfactants include, but not limited to: POE sorbitan fatty acid esters such as POE-sorbitan monostearate, POE-sorbitan monooleate, and POE-sorbitan tetraoleate; POE sorbit fatty acid esters such as POE-sorbit monooleate, POE-sorbit pentaoleate, and POE-sorbit monostearate; POE glycerin fatty acid esters such as POE-glycerin monostearate, POE-glycerin monoisostearate, and POE-glycerin triisostearate; POE fatty acid esters such as POE-monooleate, POE-distearate, POE-monodioleate, and ethylene glycol stearate; POE alkyl ethers such as POE-lauryl ether, POE-oleyl ether, POE-stearyl ether, POE-behenyl ether, POE2-octyldodecyl ether, and POE-cholestanol ether; POE alkylphenyl ethers such as POE-octylphenyl ether, POE-nonylphenyl ether, POE-nonylphenyl ether, and POE-dinonyl phenyl ether; pluaronics such as bluronic; POE•POP alkyl ethers such as POE•POP-cetyl ether, POE•POP2-decyltetradecyl ether, POE•POP-monobutyl ether, POE•POP hydrogenated lanolin, and POE•POP-glycerin ether; tetra POE•tetra POP ethylenediamine condensates such as tetronic; POE castor oil derivatives or hydrogenated castor oil derivatives such as POE castor oil, POE hydrogenated castor oil, POE hydrogenated castor oil monoisostearate, POE hydrogenated castor oil triisostearate, POE hydrogenated castor oil monopyroglutamic acid monoisostearic acid diester, and POE hydrogenated castor oil maleic acid; bees wax lanolin derivatives such as POE sorbit bees wax; glycerin fatty acid esters such as glycerin monostearate; polyglycerin fatty acid esters such as diglycerin diisostearate, decaglyceryl monostearate, decaglyceryl monoisostearate, decaglyceryl monooleate, decaglyceryl dioleate, and decaglyceryl triisostearate; sorbitan fatty acid esters such as sorbitan monooleate, sorbitan monoisostearate, sorbitan monostearate, sorbitan sesquioleate, sorbitan trioleate, diglycerol sorbitan penta-2-ethylhexylate, diglycerol sorbitan tetra-2-ethylhexylate; alkanolamides such as coconut oil fatty acid diethanolamide, lauric acid monoethanolamide, and fatty acid isopropanolamide; POE propylene glycol fatty acid ester, POE alkylamine, POE fatty acid amide, sucrose fatty acid ester, POE nonylphenylformaldehyde condensate, alkylethoxydimethylamine oxide, trioleyl phosphate; and dimethicone copolyols such as POE-modified dimethylpolysiloxane and POE•POP-modified dimethylpolysiloxane.
- Examples of anionic surfactants include, but not limited to: higher fatty acid salts such as potassium stearate and potassium behenate; alkyl ether carboxylic acid salts such as sodium POE lauryl ether carboxylate; N-acyl-L-glutamic acid salts such as N-stearoyl-L-glutamic acid monosodium salt; higher alkyl sulfuric acid ester salts such as sodium lauryl sulfate and potassium lauryl sulfate; alkyl ether sulfuric acid ester salts such as POE triethanolamine lauryl sulfate and POE sodium lauryl sulfate; N-acyl sarcosinic acid salts such as sodium lauroyl sarcosinate; higher fatty acid amide sulfonates such as N-myristoyl-N-methyltaurine sodium; alkyl phosphoric acid salts such as sodium stearyl phosphate; alkyl ether phosphoric acid salts such as sodium POE oleyl ether phosphate and sodium POE stearyl ether phosphate; sulfosuccinic acid salts such as sodium di-2-ethylhexyl sulfosuccinate, sodium monolauroyl monoethanolamide polyoxyethylene sulfosuccinate, and sodium lauryl polypropylene glycol sulfosuccinate; alkylbenzenesulfonic acid salts such as sodium linear dodecylbenzenesulfonate, linear dodecylbenzene, triethanolamine sulfonate, and linear dodecylbenzenesulfonic acid; and higher fatty acid ester sulfuric acid ester salts such as hydrogenated coconut oil fatty acid glycerin sodium sulfate.
- Examples of cationic surfactants include, but not limited to, alkyltrimethylammonium salts such as stearyltrimethylammonium chloride and lauryltrimethylammonium chloride, dialkyldimethylammonium salts such as distearyldimethylammonium chloride, poly(N,N-dimethyl-3,5-methylenepiperidinium) chloride, alkylpyridinium salts such as cetylpyridinium chloride, alkyl quaternary ammonium salts, alkyldimethylbenzylammonium salts, alkylisoquinolinium salts, dialkyl morphonium salts, POE alkylamines, alkylamine salts, polyamine fatty acid derivatives, amyl alcohol fatty acid derivatives, benzalkonium chloride, and benzethonium chloride.
- Examples of amphoteric surfactants include, but not limited to: imidazoline type amphoteric surfactants such as 2-undecyl-N,N,N-(hydroxyethyl carboxymethyl)-2-imidazoline sodium salt and 2-cocoyl-2-imidazolinium hydroxide-1-carboxyethyloxy 2 sodium salt; and betaine type surfactants such as 2-heptadecyl-N-carboxymethyl-N-hydroxyethyl imidazolinium betaine, lauryldimethylaminoacetic acid betaine, alkyl betaine, amide betaine, and sulfobetaine.
- The emulsifier is not particularly limited so long as it is commonly used in cosmetics, and, for example, a polymer that functions as a polymer emulsifier can be used. Examples of such polymers include acrylic acid/alkyl methacrylate copolymers, and commercially available products known as Carbopol 1342, Pemulen TR-1, and Pemulen TR-2 can be used.
- Water
- The cosmetic according to the present invention comprises water as the aqueous component. This water is not limited in particular. For example, purified water, ion-exchanged water, or tap water can be used.
- Aqueous components commonly used in cosmetics other than water, such as water-soluble alcohol and the like, can be blended to the aqueous phase of the cosmetic according to the present invention within the range of not adversely affecting the effect of the present invention.
- Examples of water-soluble alcohols include, but not limited to, lower alcohols, polyhydric alcohols, polyhydric alcohol polymers, dihydric alcohol alkyl ethers, dihydric alcohol ether esters, glycerin monoalkyl ethers, and sugar alcohols.
- Examples of lower alcohols include, but not limited to, ethanol, propanol, isopropanol, isobutyl alcohol, and t-butyl alcohol.
- Examples of polyhydric alcohols include, but not limited to: dihydric alcohols (e.g., dipropylene glycol, 1,3-butylene glycol, ethylene glycol, trimethylene glycol, 1,2-butylene glycol, tetramethylene glycol, 2,3-butylene glycol, pentamethylene glycol, 2-butene-1,4-diol, hexylene glycol, and octylene glycol); trihydric alcohols (e.g., glycerin and trimethylolpropane); tetrahydric alcohols (e.g., diglycerin and pentaerythritol such as 1,2,6-hexanetriol); pentahydric alcohols (e.g., xylitol and triglycerin); hexahydric alcohols (e.g., sorbitol and mannitol); polyhydric alcohol polymers (e.g., diethylene glycol, dipropylene glycol-triethylene glycol, polypropylene glycol, tetraethylene glycol, diglycerin-triglycerin, tetraglycerin, and polyglycerin); dihydric alcohol alkylethers (e.g., ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, ethylene glycol monophenyl ether, ethylene glycol monohexyl ether, ethylene glycol mono 2-methyl hexyl ether, ethylene glycol isoamyl ether, ethylene glycol benzyl ether, ethylene glycol isopropyl ether, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, ethylene glycol dibutyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol butyl ether, diethylene glycol methylethyl ether, triethylene glycol monomethyl ether, triethylene glycol monoethyl ether, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol monobutyl ether, propylene glycol isopropyl ether, dipropylene glycol methyl ether, dipropylene glycol ethyl ether, and dipropylene glycol butyl ether); dihydric alcohol ether esters (e.g., ethylene glycol monomethyl ether acetate, ethylene glycol monoethyl ether acetate, ethylene glycol monobutyl ether acetate, ethylene glycol monophenyl ether acetate, ethylene glycol diadipate, ethylene glycol disuccinate, diethylene glycol monoethyl ether acetate, diethylene glycol monobutyl ether acetate, propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether acetate, propylene glycol monopropyl ether acetate, and propylene glycol monophenyl ether acetate); glycerin mono alkyl ethers (e.g., xylyl alcohol, selachyl alcohol, and batyl alcohol); sugar alcohols (e.g., maltotriose, mannitol, sucrose, erythritol, glucose, fructose, starch amylolysis sugar, maltose, and alcohol prepared by the reduction of starch amylolysis sugar); glysolid; tetrahydro furfuryl alcohol; POE-tetrahydro furfuryl alcohol; POP-butyl ether; POP/POE-butyl ether; tripolyoxypropylene glycerin ether; POP-glycerin ether; POP-glycerin ether phosphoric acid; POP/POE-pentane erythritol ether; and polyglycerin.
- Other components commonly used in cosmetics can be blended to the cosmetic of the present invention within the range of not adversely affecting the effect of the present invention. Examples of such components include, but not limited to, moisturizers, ultraviolet absorbents, medicinal components, transdermal absorption promoters, sequestrants, powder components, vitamins, pH adjusters, antioxidants, antiseptic agents, antibacterial agents, neutralizers, perfumes and pigments.
- The cosmetic of the present invention can be in a product form such as lotions, emulsions, beauty serums, creams, and makeup bases. Lotions, emulsions, and beauty serums are particularly preferred.
- The cosmetic according to the present invention can be prepared by an ordinary method. For example, it may be prepared by: mixing and dissolving oil phase components; and adding the solution while stirring to aqueous phase components to emulsify.
- The present invention will now be explained in more detail with Examples, but the scope of the present invention is not limited by these Examples. Moreover, the blending amounts in the Examples is in “% by mass” unless specified otherwise.
- First, the methods for synthesizing precisely synthesized sodium polyacrylates used in the Examples are described.
- Acrylic acid (2511 mg) and V-501 (0.17 mg) were dissolved in ion-exchanged water (9 mL), a methanol solution (1 ml) in which CPD (0.17 mg) had been dissolved was added, and a polymerization reaction was carried out under an argon atmosphere at 60° C. for 24 hours. After the polymerization reaction, sodium hydroxide aqueous solution was added for adjusting the pH to 6.0 to 7.0, and the mixture was dialyzed against purified water for 4 days. After freeze-drying, precisely synthesized sodium polyacrylate-1 (1.82 g, yield: 72%) was collected. As a result of GPC analysis, the weight-average molecular weight was 7,300,000, and the molecular weight distribution was 1.2.
- Acrylic acid (2514 mg), methylenebisacrylamide (9.6 μg), and V-501 (0.17 mg) were dissolved in ion-exchanged water (9 ml), a methanol solution (1 ml) in which CPD (0.17 mg) had been dissolved was added, and a polymerization reaction was carried out under an argon atmosphere at 60° C. for 24 hours. After the polymerization reaction, sodium hydroxide aqueous solution was added for adjusting the pH to 6.0 to 7.0, and the mixture was dialyzed against purified water for 4 days. After freeze-drying, precisely synthesized sodium polyacrylate-2 (1.99 g, yield: 79%) was collected. As a result of GPC analysis, the weight-average molecular weight was 3,260,000, and the molecular weight distribution was 1.7.
- Acrylic acid (120 g) and V-501 (0.12 g) were dissolved in ion-exchanged water (760 g), a methanol solution (95 g) in which CPD (0.12 g) had been dissolved was added, and a polymerization reaction was carried out under an argon atmosphere at 60° C. for 96 hours. After the polymerization reaction, sodium hydroxide aqueous solution was added for adjusting the pH to 6.0 to 7.0, and the mixture was purified by re-precipitation using water/acetone. After drying under reduced pressure, precisely synthesized sodium polyacrylate-3 (75.6 g, yield: 63%) was collected. As a result of GPC analysis, the weight-average molecular weight was 695,000, and the molecular weight distribution was 1.3.
- Other components marked with * in Tables 1 and 2 below are as follows.
- *1: Pemulen TR-2 (manufactured by BF Goodrich)
- *2, 3: Sodium salt of polyacrylic acid (partially neutralized)
- The content of molecular species having a molecular weight of 10,000,000 or more and the content of the compound having a molecular weight equal three times or greater than the weight-average molecular weight are both more than 10% by mass (already analyzed in Patent Literature 2).
- Oil-in-water emulsion cosmetics (beauty serums) having the formulations shown in Tables 1 and 2 were prepared by the following production methods, and the physical properties were evaluated by the following methods. Furthermore, the actual application tests were carried out by professional panelists for the following items (1) to (6). The results are shown in Tables 1 and 2.
- Production Method
- Dimethicone and triethylhexanoin were mixed and dissolved (=mixture A), and the remaining components other than potassium hydroxide were uniformly dissolved (=mixture B). The mixture A was gradually added to the mixture B, and the resultant was mixed by a homogenizer. Furthermore, potassium hydroxide was added and processed by the homogenizer, and thus a predetermined beauty serum was obtained.
- Physical Property Evaluation
- Viscosity
- Each composition was stored at 25° C. and then rotated (12 rpm) for one minute to measure the viscosity value (mPa s) with a B-type rotational viscometer (Vismetron viscometer, manufactured by Shibaura Systems Co., Ltd.).
- pH
- The pH at 25° C. was measured with a pH meter (HORIBA pH METER F-52, manufactured by HORIBA Ltd.).
- Gradient of First Normal Stress Difference
- The first normal stress difference of each composition was calculated, and then the calculated first normal stress difference was divided by the shear velocity (see Patent Literature 1). The value obtained thereby was calculated as the gradient of the first normal stress difference. The measurement value of the first normal stress difference (Pa) with respect to the shear velocity (s−1) at the shear velocity of 100 s−1 or more was plotted, and the slope by linear approximation was calculated as the slope of the first normal stress difference (Pa-s).
- Viscoelastic Ratio (Tan δ)
- The change in elastic modulus of the composition corresponding to the change in strain upon applying a frequency of 1 Hz was measured, and a loss elastic modulus G″ and a storage elastic modulus G′ under specific strain conditions were calculated. The value obtained as the ratio therebetween, i.e., G″/G′, was regarded as the viscoelastic ratio.
- Actual Application Test
- Ten professional panelists applied the test compositions to their faces, and evaluated whether the test compositions were effective or not in: (1) rich feeling, (2) full-bodied feeling, (3) freshness, (4) non-stringiness, (5) good spreadability, and (6) non-stickiness. The answers were totalized according to the following criteria, and the results are shown in the tables.
- A (⊚): Nine or more panelists answered “effective”.
- B (∘): Seven or more and eight or fewer panelists answered “effective”.
- C (Δ): Five or more and six or fewer panelists answered “effective”.
- D (x): Four or fewer panelists answered “effective”.
- In the present invention, A and B were determined as being acceptable, and C and D were determined as being unacceptable.
-
TABLE 1 Comparative Example Comparative Example Comparative Example Comparative Example Comparative Example Example 1 1 Example 2 2 Example 3 3 Example 4 4 Example 5 5 Formulation (b) Carboxyvinyl polymer 0.1 0.1 — — — — — — — — Crosslinked sodium N,N- — — 0.3 0.3 — — — — — — dimethylacrylamide-2-acrylamide-2- methylpropanesulfonic acid copolymer (Acryloyldimethyltaurate/VP) copolymer — — — — 0.4 0.4 — — — — (Acryloyldimethyltaurine salt/beheneth-25 — — — — — — 0.4 0.4 — — methacrylate) copolymer (Acrylates/alkyl (C10-30) 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 acrylate) crosspolymer * Agar — — — — — — — — 1.0 1.0 (a) Precisely synthesized sodium polyacrylate — 0.5 — 0.5 — 0.5 — 0.5 — 0.5 (Synthesis Example 1) Other Glycerin 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 components 1,3-Butylene glycol 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 Dimethicone 3.0 3 0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 Triethylhexanoin 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 Potassium hydroxide 0.06 0.30 0.30 0.30 0.30 0.30 0.30 0.30 0.30 0.30 Methylparaben Suitable Suitable Suitable Suitable Suitable Suitable Suitable Suitable Suitable Suitable amount amount amount amount amount amount amount amount amount amount EDTA—2Na Suitable Suitable Suitable Suitable Suitable Suitable Suitable Suitable Suitable Suitable amount amount amount amount amount amount amount amount amount amount Ion-exhanged water Balance Balance Balance Balance Balance Balance Balance Balance Balance Balance Total 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 Evaluation Viscosity (Pa · s) 0.89 0.53 1.01 0.86 1.87 1.41 1.55 1.04 2.31 3.59 pH 6.3 6.8 6.2 6.7 6.3 6.9 6.4 7.0 6.0 6.7 Gradient of the first normal stress difference 0.073 0.279 0.092 0.283 0.109 0.269 0.115 0.246 0.043 0.137 Viscoelastic ratio 0.31 1.34 0.31 1.27 0.16 1.04 0.17 1.35 0.18 0.26 (1) Rich feeling C A C A C A C A C A (2) Full-bodied feeling C A C A C A C A C A (3) Freshness B B A B B B B B A B (4) Non-stringiness A A A A A A A A A A (5) Spreadability B A B A B B B B B A (6) Non-stickiness B A B A B A B A B A - As shown in Table 1, the beauty serum containing (b): (acrylates/alkyl (C10-30) acrylate) crosspolymer and a carboxyvinyl polymer, which are not precisely synthesized polymers, as thickeners were excellent in freshness, non-stringiness, spreadability, and non-stickiness, but not sufficient in rich feeling and full-bodied feeling (Comparative Example 1). On the other hand, in the beauty serum in which the precisely synthesized sodium polyacrylate (Synthesis Example 1) was added to the formulation of Comparative Example 1, the viscoelastic ratio (tan δ) and the gradient of the first normal stress difference significantly increased, and thus extremely good rich feeling and full-bodied feeling could be achieved in addition to the effects such as freshness and the like (Example 1).
- Similarly, in any of the beauty serums containing (b): (acrylates/alkyl (C10-30) acrylate) crosspolymer in combination with a crosslinked sodium N,N-dimethylacrylamide-2-acrylamido-2-methylpropanesulfonic acid copolymer (Comparative Example 2), (acryloyldimethyltaurate/VP) copolymer (Comparative Example 3), (acryloyldimethyltaurine salt/beheneth-25 methacrylate) copolymer (Comparative Example 4), or agar (Comparative Example 5), which are not precisely synthesized polymers, as thickeners, neither rich feeling nor full-bodied feeling was achieved. However, in all beauty serums in which (a): precisely synthesized sodium polyacrylate (Synthesis Example 1) was added to these formulations, the viscoelastic ratio and the gradient of the first normal stress difference significantly increased, and thus extremely excellent rich feeling and full-bodied feeling were exhibited (Examples 2 to 5).
-
FIG. 1 shows the viscoelastic ratio and the gradient of the first normal stress difference when the component (a) and the component (b) are used alone or in combination. Generally, the beauty serums plotted in the first quadrant ofFIG. 1 (the viscoelastic ratio is greater than 1.0, and the gradient of the first normal stress difference is greater than 0.10) have sufficient viscoelastic ratio and gradient of the first normal stress difference, and can be determined as being capable of exhibiting rich feeling and full-bodied feeling. - As shown in
FIG. 1 , the component (a) and the component (b) are plotted in the second quadrant or the third quadrant when used alone. However, when the component (a) and the component (b) are used in combination, the values on both the x-axis and the Y-axis becomes higher than the sum of the values obtained when the component (a) and the component (b) are used alone, and are plotted in the first quadrant. - Therefore, it was demonstrated that when the component (a) and the component (b) are used in combination, a synergistic effect between them is generated, and thus the viscoelastic ratio and the gradient of the first normal stress difference increase.
- From the above results, it is revealed that when the precisely synthesized polymer of the present invention is added to various thickeners that are not molecularly controlled and are commonly used in cosmetics, the viscoelastic ratio and the gradient of the first normal stress difference of the system greatly increase by the synergistic effect of both components, and thus extremely excellent rich feeling and full-bodied feeling can be achieved while retaining freshness, good spreadability, non-stickiness, and non-stringiness.
- Next, the polymer to be added was investigated.
- Specifically, not only (a): the precisely synthesized sodium polyacrylate, but also sodium polyacrylate synthesized by an ordinary method was blended, and the effect thereof was compared and examined. The results are shown in Table 2.
- In the bases to which ordinarily synthesized sodium polyacrylate-1 were added, the gradient of the first normal stress difference extremely increased in addition to the viscoelastic ratio, and excellent rich feeling and full-bodied feeling were achieved; however, stringiness was caused, and freshness was impaired (Comparative Examples 6 and 7). Moreover, in the bases to which ordinarily synthesized sodium polyacrylate-2 was added, the gradient of the first normal stress difference extremely increased in addition to the viscoelastic ratio, stringiness was caused, and rich feeling, full-bodied feeling, and freshness tended to be impaired (Comparative Examples 8 and 9).
-
TABLE 2 Comparative Example Comparative Comparative Comparative Comparative Example 4 4 Example 6 Example 7 Example 8 Example 9 formu- (b) Carboxyvinyl polymer — — — — — — lation Crosslinked sodium N-N- — — — — — — dimethylacrylamide-2-acrylamido-2- methylpropanesulfonic acid copolymer (Acryloyldimethyltaurate/VP) copolymer — — — — — — (Acryloyldimethyltaruine salt/beheneth-25 0.4 0.4 0.4 0.4 0.4 0.4 methacrylate) copolymer (Acrylates/alkyl (C10-30) acrylate) 0.07 0.07 0.07 0.07 0.07 0.07 crosspolymer *4 Agar — — — — — — (a) Precisely synthesized sodium polyacrylate — 0.5 — — — — (Synthesis example 1) Ordinarily synthesized sodium — — 0.3 0.5 — — polyacrylate-1 *2 Ordinarily synthesized sodium — — — — 0.3 0.5 polyacrylate-2 *3 Other Glycerin 5.0 5.0 5.0 5.0 5.0 5.0 compo- 1,3-Butylene glycol 3.0 3.0 3.0 3.0 3.0 3.0 nents Dimethicone 3.0 3.0 3.0 3.0 3.0 3.0 Triethylhexanoin 1.0 1.0 1.0 1.0 1.0 1.0 Potassium hydroxide 0.30 0.30 0.30 0.30 0.30 0.30 Methylparaben Suitable Suitable Suitable Suitable Suitable Suitable amount amount amount amount amount amount EDTA—2Na Suitable Suitable Suitable Suitable Suitable Suitable amount amount amount amount amount amount Ion-exchanged water Balance Balance Balance Balance Balance Balance Total 100 100 100 100 100 100 Evalu- Viscosity (Pa · s) 1.55 1.04 0.93 1.25 2.58 3.52 ation pH 6.4 7.0 7.2 7.5 6.3 6.2 Gradient of the first normal stress difference 0.115 0.246 0.472 1.536 0.491 0.898 Viscoelastic ratio 0.17 1.35 0.50 0.40 0.29 0.30 (1) Rich feeling C A B A C B (2) Full-bodied feeling C A B A C C (3) Freshness B B D D B C (4) Non-stringiness A A D D C D (5) Spreadability B B A A B B (6) Non-stickiness B A B C B C - Therefore, it was demonstrated that the effect achieved by adding the precisely synthesized sodium polyacrylate is due to the point that the polymer is molecularly controlled; that is, the weight-average molecular weight being 500,000 to 8,000,000, the content of compounds having a molecular weight of 10,000,000 or more being 10% by mass or less, and the polymer being linear.
- Next, the effect of the precisely synthesized polymer according to the present invention with respect to an emulsion was examined.
- Oil-in-water emulsion cosmetics (emulsions) having the formulations shown in Table 3 were prepared by an ordinary method, and the physical properties and the feeling upon use were evaluated in the same manner as in Test Example 1. The results are shown in Table 3.
-
TABLE 3 Com- Com- parative parative Example Example Example Example Example 10 6 7 11 8 Formu- (b) Carboxyvinyl polymer 0.18 0.15 0.15 0.18 0.15 lation (a) Precisely synthesized — 0.3 0.5 — — sodium polyacrylate (Synthesis Example 1) Precisely synthesized — — — — 0.3 sodium polyacrylate (Synthesis Example 2) Precisely synthesized — — — — — sodium polyacrylate (Synthesis Example 3) Other Glycerin 4 4 4 4 4 com- Dipropylene glycol 7 7 7 7 7 ponents Butylene glycol 3 3 3 3 3 Alcohol — — — — — Xanthan gum 0.05 0.05 0.05 0.05 0.05 Hydrogenated polydecene 4 4 4 4 4 Phytosteryl macadamiate — — — — — Pentaerythrityl — — — — — tetraethylhexanoate Cetyl ethylhexanoate 3 3 3 3 3 Vaseline — — — — — Hydrogenated palm oil 1 1 1 1 1 Dimethicone 2.7 2.7 2.7 2.7 2.7 Behenyl alcohol 1 1 1 1 1 Batyl alcohol 0.3 0.3 0.3 0.3 0.3 Isostearic acid 0.4 0.4 0.4 0.4 0.4 Stearic acid 0.3 0.3 0.3 0.3 0.3 Behenic acid 0.3 0.3 0.3 0.3 0.3 Glyceryl stearate 0.5 0.5 0.5 0.5 0.5 PEG-5 glyceryl stearate 1.5 1.5 1.5 1.5 1.5 Beheneth-20 — — — — — Citric acid — — — — — Sodium Citrate — — — — — Triethanolamine — — — 1.5 1.5 Phenoxyethanol 0.5 0.5 0.5 0.5 0.5 Potassium hydroxide 0.12 0.12 0.12 — — Ion-exhanged water Balance Balance Balance Balance Balance Total 100.0 100.0 100.0 100.0 100.0 Evalu- Gradient of the first normal 0.217 0.298 0.443 0.156 0.385 ation stress difference Viscoelastic ratio 0.30 0.41 0.52 0.41 0.69 (1) Rich feeling B A A B A (2) Full-bodied feeling B A A B A (3) Freshness C B B C B (4) Non-stringiness A A A A A (5) Spreadability C A A C A (6) Non-stickiness B B B B B Com- parative Example Example Example Example 9 12 10 11 Formu- (b) Carboxyvinyl polymer 0.15 — — — lation (a) Precisely synthesized — — — — sodium polyacrylate (Synthesis Example 1) Precisely synthesized 0.5 — — — sodium polyacrylate (Synthesis Example 2) Precisely synthesized — — 0.3 0.5 sodium polyacrylate (Synthesis Example 3) Other Glycerin 4 5 5 5 com- Dipropylene glycol 7 5 5 5 ponents Butylene glycol 3 — — — Alcohol — 5 5 5 Xanthan gum 0.05 0.07 0.07 0.07 Hydrogenated polydecene 4 3 3 3 Phytosteryl macadamiate — 0.8 0.8 0.8 Pentaerythrityl — 6 6 6 tetraethylhexanoate Cetyl ethylhexanoate 3 — — — Vaseline — 0.5 0.5 0.5 Hydrogenated palm oil 1 — — — Dimethicone 2.7 1 1 1 Behenyl alcohol 1 1.4 1.4 1.4 Batyl alcohol 0.3 0.52 0.52 0.52 Isostearic acid 0.4 — — — Stearic acid 0.3 — — — Behenic acid 0.3 — — — Glyceryl stearate 0.5 — — — PEG-5 glyceryl stearate 1.5 — — — Beheneth-20 — 0.82 0.82 0.82 Citric acid — 0.02 0.02 0.02 Sodium Citrate — 0.08 0.08 0.08 Triethanolamine 1.5 — — — Phenoxyethanol 0.5 0.5 0.5 0.5 Potassium hydroxide — — — — Ion-exhanged water Balance Balance Balance Balance Total 100.0 100.0 100.0 100.0 Evalu- Gradient of the first normal 0.512 0.013 0.173 0.267 ation stress difference Viscoelastic ratio 0.75 0.27 0.31 0.33 (1) Rich feeling A B A A (2) Full-bodied feeling A B A A (3) Freshness B B B B (4) Non-stringiness A A A A (5) Spreadability A C A A (6) Non-stickiness B B B B - As shown in Table 3, the emulsions solely blended with (b): carboxyvinyl polymer, which is not a precisely synthesized polymer, as a thickener was excellent in rich feeling, full-bodied feeling, non-stringiness, and non-stickiness, but inferior in freshness and insufficient in spreadability (Comparative Examples 10 to 12). On the other hand, in the emulsions in which the precisely synthesized sodium polyacrylate was added to the formulations of these Comparative Examples, the viscoelastic ratio (tan δ) and the gradient of the first normal stress difference significantly increased in accordance with the amount of sodium polyacrylate added, resulting in even better rich feeling and full-bodied feeling (Examples 6 to 11). Furthermore, in these Examples, freshness and spreadability were also significantly improved (Examples 6 or 7 with respect to Comparative Example 10, Example 8 or 9 with respect to Comparative Example 11, and Example 10 or 11 with respect to Comparative Example 12).
- Therefore, it was demonstrated that when the component (a) according to the present invention and the component (b) are used in combination in emulsions, the viscoelastic ratio and the gradient of the first normal stress difference increase; thus, rich feeling and full-bodied feeling are enhanced and, freshness and good spreadability are imparted, too.
- Furthermore, sodium polyacrylate was produced by a polymerization method different from the RAFT polymerization method used in the present application, and the thread length was measured. As for this method, the polymerization method that uses 2-mercaptoethanol as a chain transfer agent as disclosed in Example 1 of Japanese Patent No. 5076428 B was employed.
- Method for Producing Sodium Polyacrylate
- An aqueous solution of a monomer mixture containing 69 g (0.94 mol) of 98% acrylic acid, 245.5 g (0.94 mol) of a 36% aqueous solution of sodium acrylate, and 205 g of pure water was added to a hermetically closed three-necked flask and, while stirring the aqueous solution, dissolved oxygen was removed by argon. Under argon purge, 0.14 g of 2,2′-azobis(2-methylpropionamidine) dihydrochloride and 0.00185 g of 2-mercaptoethanol were respectively diluted with argon-purged pure water and added as 1% aqueous solutions to the monomer mixture with a syringe, and thus an aqueous solution was prepared.
- Next, the monomer mixture in which the dissolved oxygen is sufficiently replaced with argon was added to an 85.7<p polystyrene dish, lidded, and thermally polymerized in a thermostat (Model ADP300 manufactured by Yamato Scientific Co., Ltd.) at 60° C., and obtained a gel-like substance as in Example 1 of Japanese Patent No. 5076428 B (in Example 1 of Japanese Patent No. 5076428 B, the temperature was raised to about 60° C. by UV lamp irradiation, but the same conditions were reproduced with a thermostat).
- In order to remove the residual monomers, the gel-like substance was stirred and dissolved in pure water, and then dialyzed with a dialysis tube (Fisherbrand regenerated cellulose having a pore size of 10 Å). After dialysis, white polymer powder was collected by freeze-drying (FDU2100, Tokyo Rikakikai Co., Ltd.).
- Physical Property Evaluation
- Stringiness
- The apparatus and conditions described in Patent Literature 2 were used for evaluations. Specifically, a 1% by mass aqueous solution of the obtained sodium polyacrylate was prepared and stored in a container at room temperature. The container was set on a texture analyzer (TA.XT plus, manufactured by Stable Micro Systems), a round disk having a diameter of about 1 cm was uniformly and lightly brought into contact with the surface of the aqueous solution, and then the container was lowered at a velocity of 5 mm/sec to observe how the solution forms a thread. The distance that the container was lowered until the thread of the solution was cut was measured as a “thread length.” This thread length is a value that serves an index of stringiness of the polymer compound, and a greater value indicates a greater stringiness. When the thread length was 10 mm or less, the stringiness was determined as being low.
- Aqueous Solution Viscosity Measurement
- 39.92 g of pure water was added to a 50 ml glass screw tube. 0.08 g of sodium polyacrylate was added thereto, and the mixture was stirred for 10 minutes with a planetary mixer (Sinky Corporation, ARE-100) to give a 0.2% by mass aqueous solution. The viscosity of the prepared solution was measured with a B-type viscometer under the condition of 20° C. and 30 rpm.
- As a control, with respect to the precisely synthesized sodium polyacrylate-1 synthesized by the method disclosed in Synthesis Example 1 of the present description, 39.92 g of pure water was put into a 50 ml glass screw tube, 0.08 g of sodium polyacrylate was added thereto, and the mixture was stirred for 10 minutes with a planetary mixer (Sinky Corporation, ARE-100) to give a 0.2% by weight aqueous solution. After repeating the preparation for two times, the samples were put together in a 100 mL glass screw tube, and the viscosity was measured with a B-type viscometer under the condition of 20° C. and 30 rpm.
- Results
- With respect to the 1% aqueous solution of sodium polyacrylate produced by the polymerization method that was not the RAFT polymerization method, stringiness was clearly recognized even by visual observation (the viscous and thread-forming state were observed during the measurement), and the measured thread length was 12 mm. Moreover, the viscosity of the 0.2% by mass aqueous solution of the sodium polyacrylate was 560 mPa s.
- On the other hand, the precisely synthesized sodium polyacrylate-1 synthesized by the method of Synthesis Example 1 of the present application did not show any stringiness by visual observation, and the thread length was 6 mm. In addition, the viscosity of the 0.2% by mass aqueous solution of the sodium polyacrylate was 64.4 mPa-s. It is generally known that the stringiness of a polymer tends to correlate with viscosity and viscoelasticity.
- Therefore, it was verified that the stringiness of a polymer greatly varies according to the synthesis method of the polymer, and when the RAFT polymerization method is used, a polymer having a much lower stringiness (than when a polymerization method that uses a chain transfer agent other than the RAFT agent is used) can be obtained.
- Formulation examples of the cosmetics according to the present invention are listed in the following, but the present invention is not limited thereto. The following cosmetics were produced by ordinary methods unless specified otherwise.
-
Formulation Example 1: Cosmetic Lotion Formulation Blending amount Component (% by mass) Ethyl alcohol 5 Glycerin 1 1,3- Butylene glycol 5 Polyoxyethylene polyoxypropylene 0.2 decyltetradecyl ether Sodium hexametaphosphate 0.03 Trimethylglycine 1 Sodium polyaspartate 0.1 Ascorbic acid dl-α-tocopherol 0.1 phosphoric acid diester potassium salt Thiotaurine 0.1 Green tea extract 0.1 Mentha Piperita (Peppermint) leaf 0.1 extract Iris Florentina Root extract 1 EDTA 3Na 0.1 Carboxyvinyl polymer 0.05 Precisely synthesized sodium 0.01 poly acrylate (Synthesis Example 1) Potassium hydroxide 0.02 Phenoxyethanol Suitable amount Perfume Suitable amount Purified water Balance Total: 100.0 -
Formulation Example 2: Cosmetic Lotion Blending Formulation amount Component (% by mass) Dipropylene glycol 5 Glycerin 6 Butylene glycol 7 Polyethylene glycol 5 Methyl gluceth-10 2 Triethylhexanoin 0.3 PEG-60 hydrogenated castor oil 0.5 Polyglyceryl-2 diisostearate 0.4 Carboxyvinyl polymer 0.05 Precisely synthesized sodium 0.05 polyacrylate (Synthesis Example 1) Potassium hydroxide 0.02 Tranexamic acid 1 Sodium alginate 0.1 Citric acid Suitable amount Phenoxyethanol Suitable amount Sodium metaphosphate Suitable amount Perfume Suitable amount Purified water Balance Total: 100.0 -
Formulation Example 3: Cosmetic Lotion Formulation Blending amount Component (% by mass) Glycerin 2 1,3-Butylene glycol 4 Erythritol 1 Polyoxyethylene methyl glucoside 1 Polyoxyethylene hydrogenated castor oil 0.5 Dimethyl acrylamide Crosslinked sodium N,N-dimethylacrylamide-2- acrylamido-2-methylpropanesulfonic acid copolymer Precisely synthesized sodium polyacrylate 0.03 (Synthesis Example 2) N-coconut oil fatty acid acyl-L-arginine-ethyl 0.1 DL-pyrrolidonecarboxylic acid Citric acid 0.02 Sodium citrate 0.08 Phenoxyethanol Suitable amount Purified water Balance Total: 100.0 -
Formulation Example 4: Cosmetic Lotion Formulation Blending amount Component (% by mass) Glycerin 10 Ethanol 5 Dipropylene glycol 6 PEG/PPG-14/7 dimethyl ether 1 PPG-1 3 decyltetradeceth-24 0.5 (Acryloyldimethylltaurate/VP) copolymer 0.05 Precisely synthesized sodium polyacrylate 0.03 (Synthesis Example 3) Lactic acid 1 Tranexamic acid 2 Xanthan gum 0.1 Citric acid Suitable amount Sodium citrate Suitable amount Phenoxyethanol Suitable amount Disodium edetate Suitable amount Perfume Suitable amount Purified water Balance Total: 100.0 -
Formulation Example 5: Cosmetic Lotion Formulation Blending amount Component (% by mass) Mineral oil 0.5 Isostearyl alcohol 0.5 Glycerin 4 Dipropylene glycol 5 Butylene glycol 5 Polyethylene glycol 4 Isostearic acid 1 PEG/PPG-14/7 dimethyl ether 5 Sorbitan sesquiisostearate 0.3 PEG-30 soy sterol 1 (Acryloyldimethyltaurate/beheneth-25 0.05 methacrylate) copolymer Precisely synthesized sodium polyacrylate 0.05 (Synthesis Example 3) Tranexamic acid 1 Dipotassium glycyrrhizinate 0.05 Citric acid Suitable amount Sodium metaphosphate Suitable amount Phenoxyethanol Suitable amount Perfume Suitable amount Purified water Balance Total: 100.0 -
Formulation Example 6: Whitening Emulsion Formulation Blending amount Component (% by mass) Hydrogenated polydecene 1 Dimethicone 1 Cyclomethicone 2 Behenyl alcohol 0.2 Batyl alcohol 0.1 Glycerin 1 Butylene glycol 8 Cetyl ethylhexanoate 2 Polysorbate 60 0.1 PEG-60 hydrogenated castor oil 0.1 Ascorbyl glucoside 2 Xanthan gum 0.05 Sodium polyacrylate/acryloyldimethyl 2.5 taurate copolymer dispersion (actual content) Acrylic acid/alkyl methacrylate 0.1 copolymer Precisely synthesized sodium 0.5 polyacrylate (Synthesis Example 1) Disodium edetate Suitable amount Potassium hydroxide Suitable amount Citric acid Suitable amount Sodium metaphosphate Suitable amount Phenoxyethanol Suitable amount Iron oxide Suitable amount Purified water Balance Total: 100.0 -
Formulation Example 7: Emulsion Formulation Blending amount Component (% by mass) Carboxydecyl trisiloxane 1 Dimethicone 1.5 Cyclomethicone 2.5 Diphenylsiloxy phenyl trimethicone 1 Behenyl alcohol 1 Batyl alcohol ] Glycerin 2 Dipropylene glycol 7 Glyceryl stearate (SE) 1 PEG-5 glyceryl stearate 0.5 Tranexamic acid 2 Carbomer 0.1 Precisely synthesized sodium polyacrylate 0.3 (Synthesis Example 2) Potassium hydroxide Suitable amount Sodium metaphosphate Suitable amount Iron oxide Suitable amount Phenoxyethanol Suitable amount Di sodium edetate Suitable amount Perfume Suitable amount Purified water Balance Total: 100.0 -
Formulation Example 8: Emulsion Formulation Blending amount Component (% by mass) Hydrogenated polydecene 7 Vaseline 1 Dimethicone 1 Ethanol 2 Behenyl alcohol 1 2 Glycerin 8 Butylene glycol 4 Stearic acid 0.5 Behenic acid 0.5 Ceteth-25 0.3 Sodium stearoyl glutamate 0.3 Crosslinked sodium N,N-dimethylacrylamide-2- 0.5 acrylamido-2-methylpropanesulfonic acid copolymer Precisely synthesized sodium polyacrylate 0.8 (Synthesis Example 2) 4-Methoxysalicylic acid potassium salt 1 Tranexamic acid 2 Tocopherol acetate 1 Potassium hydroxide Suitable amount Phenoxyethanol Suitable amount Di sodium edetate Suitable amount Perfume Suitable amount Purified water Balance Total: 100.0 -
Formulation Example 9: Emulsion Formulation Blending amount Component (% by mass) Vaseline 5 Behenyl alcohol 0.5 Batyl alcohol 0.5 Glycerin 7 1,3-Butylene glycol 7 1,2- Pentanediol 1 Xylit 3 Polyethylene glycol 20000 2 Hydrogenated oil 9 Jojoba oil 2 Squalane 5 Isostearic acid 0.5 Pentaerythrityl tetra-2 -ethylhexanoate 2 Polyoxyethylene hydrogenated castor oil 0.5 Betaine lauryldimethylaminoacetate 0.4 Sodium pyrosulfite 0.01 Sodium hexametaphosphate 0.05 Dipotassium glycyrrhizinate 0.05 Trimethvlglycine 3 Arbutin 3 Yeast extract 0.1 Tocopherol acetate 0.1 Thiotaurine 0.1 Sophora Angustifolia Root extract 0.1 Pyrus Cydonia Seed extract 0.1 Carboxyvinyl polymer 0.2 Precisely synthesized sodium polyacrylate 0.3 (Synthesis Example 3) Sodium hydroxide Suitable amount Phenoxyethanol Suitable amount Red iron oxide Suitable amount Purified water Balance Total: 100.0 -
Formulation Example 10: Emulsion Formulation Blending amount Component (% by mass) Dimethyl polysiloxane 3 Decamethylcyclopentasiloxane 4 Ethanol 5 Glycerin 6 1,3- Butylene glycol 5 Polyoxyethylene methyl glucoside 3 Sunflower oil 1 Squalane 2 Potassium hydroxide 0.1 Sodium hexametaphosphate 0.05 Hydroxypropyl-β-cyclodextrin 0.1 Dipotassium glycyrrhizinate 0.05 Eriobotrya Japonica Leaf extract 0.1 L-sodium glutamate 0.05 Fennel extract 0.1 Yeast extract 0.1 Lavender oil 0.1 Rehmannia Root extract 0.1 Dimorpholinopyridazinone 0.1 Xanthan gum 0.1 Carboxyvinyl polymer 0.1 Acrylic acid/alkyl methacrylate copolymer 0.1 Precisely synthesized sodium poly acrylate 0.5 (Synthesis Example 1) Red iron oxide Suitable amount Yellow iron oxide Suitable amount Paraben Suitable amount Purified water Balance Total: 100.0 -
Formulation Example 11: Emulsion Formulation Blending amount Component (% by mass) Dimethicone 2 Ethanol 3 Behenyl alcohol 1 Glycerin 3 Dipropylene glycol 5 Butylene glycol 3 Triethylhexanoin 1 Sodium methyl stearoyl taurate 0.1 Citric acid 0.18 Sodium citrate 0.02 Tranexamic acid 2 Xanthan gum 0.05 (Acryl oyldimethyl taurate/beheneth-25 methacrylate) 0.5 copolymer Precisely synthesized sodium polyacrylate 0.5 (Synthesis Example 1) Phenoxyethanol Suitable amount Disodium edetate Suitable amount Perfume Suitable amount Purified water Balance Total: 100.0 -
Formulation Example 12: Emulsion Formulation Blending amount Component (% by mass) Dimethyl poly siloxane 3 Methylphenyl polysiloxane 3 Ethanol 5 Glycerin 4 Di propylene glycol 5 1,3- Butylene glycol 5 Di-2-ethylhexyl succinate 3.5 Potassium hydroxide 0.1 Sodium hexametaphosphate 0.1 Thiotaurine 0.1 Edetate trisodium 0.1 4-t-butyl-4′-methoxy dibenzoylemethane 3 2- Ethylhexyl p-methoxycinnamate 3 Iron oxide 0.01 Acrylic acid/alkyl methacrylate copolymer 0.1 (Acryloyldimethylltaurate/VP) copolymer 0.05 Precisely synthesized sodium poly acrylate 0.5 (Synthesis Example 2) Paraben Suitable amount Perfume Suitable amount Purified water Balance Total: 100.0 -
Formulation Example 13: Gel Formulation Blending amount Component (% by mass) Dimethyl polysiloxane 5 Glycerin 2 1,3- Butylene glycol 5 Polyethylene glycol 1500 3 Polyethylene glycol 20000 3 Cetyl octanoate 3 Citric acid 0.01 Sodium citrate 0.1 Sodium hexametaphosphate 0.1 Dipotassium glycyrrhizinate 0.1 Ascorbyl glucoside 2 Tocopherol acetate 0.1 Scutellaria Baicalensis extract 0.1 Saxifraga Sarmentosa extract 0.1 Edetate trisodium 0.1 Xanthan gum 0.3 Acrylic acid/alkyl methacrylate copolymer 0.05 Agar powder 1.5 Precisely synthesized sodium polyacrylate 0.2 (Synthesis Example 1) Phenoxyethanol Suitable amount Dibutyl hydroxytoluene Suitable amount Purified water Balance Total: 100.0 - Production Method
- A translucent emulsion composition was produced by an ordinary method and cooled to 30° C. or lower to be gelated. When the gel was sufficiently solidified, the gel was crushed by a disper to give a microgel (having an average particle size of 70 μm). Then the microgel was degassed to give a gel-like product.
-
Formulation Example 14: Beauty Serum Formulation Biending amount Component (% by mass) Ethanol 10 PPG-13 decyltetradeceth-24 0.1 Salicylic acid 0.5 Tranexamic acid 1 Xanthan gum 0.2 Gellan gum 0.5 Sodium chloride 0.9 Potassium hydroxide Suitable amount Sodium pyrosulfite Suitable amount Disodium edetate Suitable amount Purified water Balance Total: 100.0
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/873,515 US20220354767A1 (en) | 2017-12-28 | 2022-07-26 | Method of Thickening Cosmetic Composition |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017-254469 | 2017-12-28 | ||
JP2017254469A JP6950524B2 (en) | 2017-12-28 | 2017-12-28 | Hybrid vehicle control device |
PCT/JP2018/048064 WO2019131845A1 (en) | 2017-12-28 | 2018-12-27 | Cosmetic |
US202016954504A | 2020-06-16 | 2020-06-16 | |
US17/873,515 US20220354767A1 (en) | 2017-12-28 | 2022-07-26 | Method of Thickening Cosmetic Composition |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2018/048064 Division WO2019131845A1 (en) | 2017-12-28 | 2018-12-27 | Cosmetic |
US16/954,504 Division US20210085591A1 (en) | 2017-12-28 | 2018-12-27 | Cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
US20220354767A1 true US20220354767A1 (en) | 2022-11-10 |
Family
ID=66816912
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/217,314 Expired - Fee Related US10717428B2 (en) | 2017-12-28 | 2018-12-12 | Control system of hybrid vehicle |
US17/873,515 Abandoned US20220354767A1 (en) | 2017-12-28 | 2022-07-26 | Method of Thickening Cosmetic Composition |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/217,314 Expired - Fee Related US10717428B2 (en) | 2017-12-28 | 2018-12-12 | Control system of hybrid vehicle |
Country Status (4)
Country | Link |
---|---|
US (2) | US10717428B2 (en) |
JP (1) | JP6950524B2 (en) |
CN (1) | CN109969158B (en) |
DE (1) | DE102018131442B4 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021038710A1 (en) * | 2019-08-27 | 2021-03-04 | 本田技研工業株式会社 | Vehicle control device |
CN110979299B (en) * | 2019-09-30 | 2024-02-23 | 苏州益高电动车辆制造有限公司 | Hybrid electric vehicle, control method, computer device, and readable storage medium |
JP6970156B2 (en) | 2019-10-18 | 2021-11-24 | トヨタ自動車株式会社 | Data generation method used for vehicle control, vehicle control device, vehicle control system, in-vehicle device and vehicle learning device |
CN110682926B (en) * | 2019-11-05 | 2020-11-13 | 中车株洲电力机车有限公司 | Control method and device for internal electric hybrid power locomotive |
JP7384148B2 (en) * | 2020-12-01 | 2023-11-21 | トヨタ自動車株式会社 | Vehicle control device and internal combustion engine control device |
JP2023005487A (en) * | 2021-06-29 | 2023-01-18 | 株式会社クボタ | Agricultural machine, and device and method for controlling agricultural machine |
FR3133580A1 (en) * | 2022-03-16 | 2023-09-22 | Psa Automobiles Sa | Method and device for managing the operating mode of a motor vehicle |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4999183A (en) * | 1989-10-02 | 1991-03-12 | Leonard Mackles | Shaving compositions |
JPH04352719A (en) * | 1990-06-29 | 1992-12-07 | Santen Pharmaceut Co Ltd | Auxiliary agent for removing remaining crystalline lens material |
US20020177680A1 (en) * | 2000-08-23 | 2002-11-28 | Hubbell Jeffrey A. | Novel polymer compounds |
US20030068342A1 (en) * | 2001-05-11 | 2003-04-10 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Cosmetic cream cleanser |
KR20120047234A (en) * | 2009-07-08 | 2012-05-11 | 데르미라 (캐나다), 인코포레이티드 | Tofa analogs useful in treating dermatological disorders or conditions |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000205925A (en) * | 1999-01-07 | 2000-07-28 | Nissan Motor Co Ltd | Vehicular fuel consumption indicator |
EP1707430A1 (en) * | 2004-01-16 | 2006-10-04 | Yamaha Hatsudoki Kabushiki Kaisha | Hybrid vehicle |
JP4280870B2 (en) * | 2007-05-18 | 2009-06-17 | トヨタ自動車株式会社 | Hybrid vehicle |
JP2009280139A (en) * | 2008-05-23 | 2009-12-03 | Denso Corp | Onboard device and program |
JP2011073611A (en) * | 2009-09-30 | 2011-04-14 | Fuji Heavy Ind Ltd | Control device of hybrid vehicle |
US8793067B2 (en) * | 2009-12-28 | 2014-07-29 | Honda Motor Co., Ltd. | Route searching device |
JP5497598B2 (en) * | 2010-09-15 | 2014-05-21 | トヨタ自動車株式会社 | Vehicle control device |
JP2013126788A (en) * | 2011-12-16 | 2013-06-27 | Denso Corp | Vehicle running mode switching device |
JP2013141858A (en) | 2012-01-10 | 2013-07-22 | Toyota Motor Corp | Controller for hybrid vehicle |
JP2014073732A (en) * | 2012-10-03 | 2014-04-24 | Hino Motors Ltd | Hybrid vehicle control device, hybrid vehicle and hybrid vehicle control method |
JP2015202807A (en) | 2014-04-15 | 2015-11-16 | トヨタ自動車株式会社 | Vehicle control device |
JP2015202806A (en) * | 2014-04-15 | 2015-11-16 | トヨタ自動車株式会社 | Vehicle control device |
DE102014012318B4 (en) | 2014-08-19 | 2019-05-09 | Audi Ag | A method for predicting a consumption of a motor vehicle, motor vehicle and computer program |
JP6269388B2 (en) * | 2014-08-21 | 2018-01-31 | トヨタ自動車株式会社 | Vehicle control device |
MX373506B (en) * | 2014-09-09 | 2020-05-05 | Nissan Motor | HYBRID VEHICLE CONTROL DEVICE. |
EP3173304A1 (en) | 2015-11-25 | 2017-05-31 | Magna Steyr Fahrzeugtechnik AG & Co KG | Method for determining a driving route |
JP6520902B2 (en) | 2016-12-14 | 2019-05-29 | トヨタ自動車株式会社 | Connected vehicle |
-
2017
- 2017-12-28 JP JP2017254469A patent/JP6950524B2/en active Active
-
2018
- 2018-12-04 CN CN201811474265.XA patent/CN109969158B/en active Active
- 2018-12-07 DE DE102018131442.6A patent/DE102018131442B4/en active Active
- 2018-12-12 US US16/217,314 patent/US10717428B2/en not_active Expired - Fee Related
-
2022
- 2022-07-26 US US17/873,515 patent/US20220354767A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4999183A (en) * | 1989-10-02 | 1991-03-12 | Leonard Mackles | Shaving compositions |
JPH04352719A (en) * | 1990-06-29 | 1992-12-07 | Santen Pharmaceut Co Ltd | Auxiliary agent for removing remaining crystalline lens material |
US20020177680A1 (en) * | 2000-08-23 | 2002-11-28 | Hubbell Jeffrey A. | Novel polymer compounds |
US20030068342A1 (en) * | 2001-05-11 | 2003-04-10 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Cosmetic cream cleanser |
KR20120047234A (en) * | 2009-07-08 | 2012-05-11 | 데르미라 (캐나다), 인코포레이티드 | Tofa analogs useful in treating dermatological disorders or conditions |
Non-Patent Citations (5)
Title |
---|
Al-Malah, Rheological Properties of Carbomer Dispersions, ANNUAL TRANSACTIONS OF THE NORDIC RHEOLOGY SOCIETY, VOL. 14, 2006 (Year: 2006) * |
Cosmetic Ingredient Review, Final Safety Assessment: Crosslinked Alkyl Acrylates as Used in Cosmetics, November 17, 2011 (Year: 2011) * |
JP-04352719-A, PE2E machine translation, 12-1992 (Year: 1992) * |
KR-20120047234-A, PE2E machine translation, 05-2012 (Year: 2012) * |
Lubrizol, Flow and Suspension Properties, Pharmaceutical Bulletin 7, Edition: Oct. 29, 2008 (Year: 2008) * |
Also Published As
Publication number | Publication date |
---|---|
CN109969158A (en) | 2019-07-05 |
CN109969158B (en) | 2022-06-14 |
DE102018131442B4 (en) | 2024-07-25 |
DE102018131442A1 (en) | 2019-07-04 |
US10717428B2 (en) | 2020-07-21 |
JP6950524B2 (en) | 2021-10-13 |
US20190202430A1 (en) | 2019-07-04 |
JP2019119308A (en) | 2019-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220354767A1 (en) | Method of Thickening Cosmetic Composition | |
US20210085591A1 (en) | Cosmetic | |
JP6949714B2 (en) | Powder type composition in oil in water | |
US11439582B2 (en) | Low-stringiness thickener and cosmetic material admixed with said thickener | |
US9707170B2 (en) | Water-based skin cosmetic | |
WO2013018584A1 (en) | Oil-in-water-type emulsion cosmetic | |
US20230338244A1 (en) | Water-in-oil emulsified cosmetic | |
JP5506106B2 (en) | Oil-in-water emulsified skin cosmetic | |
JP4577721B2 (en) | Cosmetics | |
JP7456939B2 (en) | Oil-in-water emulsion cosmetic containing retinol | |
JP5398813B2 (en) | Aqueous skin cosmetics | |
JP2013063935A (en) | Oil-in-water emulsion skin cosmetic | |
JP2021502997A (en) | Emulsion containing anionic acrylic copolymer and lipophilic polymer | |
JP5088979B1 (en) | Oil-in-water emulsified skin cosmetic | |
JP2005145860A (en) | External preparation composition for skin coloration | |
JP7520938B2 (en) | Cosmetic Composition | |
JPH11246382A (en) | Perfume composition | |
WO2024135258A1 (en) | Thickening composition, production method therefor, and cosmetic product | |
WO2023219108A1 (en) | Oil-in-water composition | |
WO2023120180A1 (en) | Oil-in-water type emulsified cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: SHISEIDO COMPANY, LTD., JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SOGABE, ATSUSHI;MATSUO, AYANO;REEL/FRAME:060639/0382 Effective date: 20200522 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |